<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37298527</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9577</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24119577</ELocationID><Abstract><AbstractText>The human gut microbiome contains the largest number of bacteria in the body and has the potential to greatly influence metabolism, not only locally but also systemically. There is an established link between a healthy, balanced, and diverse microbiome and overall health. When the gut microbiome becomes unbalanced (dysbiosis) through dietary changes, medication use, lifestyle choices, environmental factors, and ageing, this has a profound effect on our health and is linked to many diseases, including lifestyle diseases, metabolic diseases, inflammatory diseases, and neurological diseases. While this link in humans is largely an association of dysbiosis with disease, in animal models, a causative link can be demonstrated. The link between the gut and the brain is particularly important in maintaining brain health, with a strong association between dysbiosis in the gut and neurodegenerative and neurodevelopmental diseases. This link suggests not only that the gut microbiota composition can be used to make an early diagnosis of neurodegenerative and neurodevelopmental diseases but also that modifying the gut microbiome to influence the microbiome-gut-brain axis might present a therapeutic target for diseases that have proved intractable, with the aim of altering the trajectory of neurodegenerative and neurodevelopmental diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, autism spectrum disorder, and attention-deficit hyperactivity disorder, among others. There is also a microbiome-gut-brain link to other potentially reversible neurological diseases, such as migraine, post-operative cognitive dysfunction, and long COVID, which might be considered models of therapy for neurodegenerative disease. The role of traditional methods in altering the microbiome, as well as newer, more novel treatments such as faecal microbiome transplants and photobiomodulation, are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bicknell</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>NICM Health Research Institute, University of Western Sydney, Westmead, NSW 2145, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebert</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NICM Health Research Institute, University of Western Sydney, Westmead, NSW 2145, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Governance and Research, Sydney Adventist Hospital, Wahroonga, NSW 2076, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borody</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Digestive Diseases, Five Dock, NSW 2046, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herkes</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4491-8441</Identifier><AffiliationInfo><Affiliation>Department of Governance and Research, Sydney Adventist Hospital, Wahroonga, NSW 2076, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLachlan</LastName><ForeName>Craig</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9843-8980</Identifier><AffiliationInfo><Affiliation>Centre for Healthy Futures, Torrens University Australia, Ultimo, NSW 2007, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiat</LastName><ForeName>Hosen</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2899-118X</Identifier><AffiliationInfo><Affiliation>NICM Health Research Institute, University of Western Sydney, Westmead, NSW 2145, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Healthy Futures, Torrens University Australia, Ultimo, NSW 2007, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Macquarie Medical School, Macquarie University, Macquarie Park, NSW 2109, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ANU College of Health and Medicine, Australian National University, Canberra, ACT 2601, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087502" MajorTopicYN="N">Brain-Gut Axis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067877" MajorTopicYN="Y">Autism Spectrum Disorder</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">autism spectrum disorder</Keyword><Keyword MajorTopicYN="N">faecal microbiome transplants</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">neurodevelopmental disease</Keyword><Keyword MajorTopicYN="N">photobiomodulation</Keyword></KeywordList><CoiStatement>B.B and A.L are cofounders and shareholders of SYMBYX Pty Ltd., a med tech company developing protocols targeting the microbiome to address metabolic and neurodegenerative diseases.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37298527</ArticleId><ArticleId IdType="pmc">PMC10253993</ArticleId><ArticleId IdType="doi">10.3390/ijms24119577</ArticleId><ArticleId IdType="pii">ijms24119577</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walker R.W., Clemente J.C., Peter I., Loos R.J. The prenatal gut microbiome: Are we colonized with bacteria in utero? Pediatr. Obes. 2017;12:3&#x2013;17. doi: 10.1111/ijpo.12217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijpo.12217</ArticleId><ArticleId IdType="pmc">PMC5583026</ArticleId><ArticleId IdType="pubmed">28447406</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinwand J.C., Paul B., Chen R., Xu F., Sierra M.A., Paluru M.M., Nanduri S., Alcantara C.G., Shadaloey S.A., Yang F. Intrahepatic microbes govern liver immunity by programming NKT cells. J. Clin. Investig. 2022;132:e151725. doi: 10.1172/JCI151725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI151725</ArticleId><ArticleId IdType="pmc">PMC9012289</ArticleId><ArticleId IdType="pubmed">35175938</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo D.J., Rifkin R.F., Cowan D.A., Potgieter M. The Healthy Human Blood Microbiome: Fact or Fiction? Front. Cell. Infect. Microbiol. 2019;9:148. doi: 10.3389/fcimb.2019.00148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00148</ArticleId><ArticleId IdType="pmc">PMC6519389</ArticleId><ArticleId IdType="pubmed">31139578</ArticleId></ArticleIdList></Reference><Reference><Citation>Link C.D. Is there a brain microbiome? Neurosci. Insights. 2021;16:26331055211018709. doi: 10.1177/26331055211018709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/26331055211018709</ArticleId><ArticleId IdType="pmc">PMC8165828</ArticleId><ArticleId IdType="pubmed">34104888</ArticleId></ArticleIdList></Reference><Reference><Citation>Baquero F., Nombela C. The microbiome as a human organ. Clin. Microbiol. Infect. 2012;18((Suppl. S4)):2&#x2013;4. doi: 10.1111/j.1469-0691.2012.03916.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03916.x</ArticleId><ArticleId IdType="pubmed">22647038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sender R., Fuchs S., Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533. doi: 10.1371/journal.pbio.1002533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002533</ArticleId><ArticleId IdType="pmc">PMC4991899</ArticleId><ArticleId IdType="pubmed">27541692</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes A., Semenkovich N.P., Whiteson K., Rohwer F., Gordon J.I. Going viral: Next-generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbiol. 2012;10:607&#x2013;617. doi: 10.1038/nrmicro2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2853</ArticleId><ArticleId IdType="pmc">PMC3596094</ArticleId><ArticleId IdType="pubmed">22864264</ArticleId></ArticleIdList></Reference><Reference><Citation>Tierney B.T., Yang Z., Luber J.M., Beaudin M., Wibowo M.C., Baek C., Mehlenbacher E., Patel C.J., Kostic A.D. The Landscape of Genetic Content in the Gut and Oral Human Microbiome. Cell Host Microbe. 2019;26:283&#x2013;295.e8. doi: 10.1016/j.chom.2019.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.07.008</ArticleId><ArticleId IdType="pmc">PMC6716383</ArticleId><ArticleId IdType="pubmed">31415755</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59&#x2013;65. doi: 10.1038/nature08821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08821</ArticleId><ArticleId IdType="pmc">PMC3779803</ArticleId><ArticleId IdType="pubmed">20203603</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebersold R., Agar J.N., Amster I.J., Baker M.S., Bertozzi C.R., Boja E.S., Costello C.E., Cravatt B.F., Fenselau C., Garcia B.A., et al. How many human proteoforms are there? Nat. Chem. Biol. 2018;14:206&#x2013;214. doi: 10.1038/nchembio.2576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2576</ArticleId><ArticleId IdType="pmc">PMC5837046</ArticleId><ArticleId IdType="pubmed">29443976</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A.L., Bessho S., Grando K., T&#xfc;kel &#xc7;. Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases. Front. Immunol. 2021;12:638867. doi: 10.3389/fimmu.2021.638867.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.638867</ArticleId><ArticleId IdType="pmc">PMC7952436</ArticleId><ArticleId IdType="pubmed">33717189</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitan O., Johnson D.A., Macg M. The Inner-Colonic Bacterial Communities of the Human Gut are Unique and Profoundly Different than those of Stool Samples. Am. J. Gastroenterol. 2020;115:S118&#x2013;S119. doi: 10.14309/01.ajg.0000703020.43929.e5.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/01.ajg.0000703020.43929.e5</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong C.Y.L., Bloomfield F.H., O&#x2019;Sullivan J.M. Factors affecting gastrointestinal microbiome development in neonates. Nutrients. 2018;10:274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5872692</ArticleId><ArticleId IdType="pubmed">29495552</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Bello M.G., Godoy-Vitorino F., Knight R., Blaser M.J. Role of the microbiome in human development. Gut. 2019;68:1108&#x2013;1114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6580755</ArticleId><ArticleId IdType="pubmed">30670574</ArticleId></ArticleIdList></Reference><Reference><Citation>Spor A., Koren O., Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 2011;9:279. doi: 10.1038/nrmicro2540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2540</ArticleId><ArticleId IdType="pubmed">21407244</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Wang Z. Microbiota and aging. In: Wang Z., editor. Aging and Aging-Related Diseases: Mechanisms and Interventions. Springer Nature; Singapore: 2018. pp. 141&#x2013;156.</Citation></Reference><Reference><Citation>Nandwana V., Nandwana N.K., Das Y., Saito M., Panda T., Das S., Almaguel F., Hosmane N.S., Das B.C. The role of microbiome in brain development and neurodegenerative diseases. Molecules. 2022;27:3402. doi: 10.3390/molecules27113402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27113402</ArticleId><ArticleId IdType="pmc">PMC9182002</ArticleId><ArticleId IdType="pubmed">35684340</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodrich J.K., Davenport E.R., Beaumont M., Jackson M.A., Knight R., Ober C., Spector T.D., Bell J.T., Clark A.G., Ley R.E. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe. 2016;19:731&#x2013;743. doi: 10.1016/j.chom.2016.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.04.017</ArticleId><ArticleId IdType="pmc">PMC4915943</ArticleId><ArticleId IdType="pubmed">27173935</ArticleId></ArticleIdList></Reference><Reference><Citation>Falony G., Joossens M., Vieira-Silva S., Wang J., Darzi Y., Faust K., Kurilshikov A., Bonder M.J., Valles-Colomer M., Vandeputte D. Population-level analysis of gut microbiome variation. Science. 2016;352:560&#x2013;564. doi: 10.1126/science.aad3503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad3503</ArticleId><ArticleId IdType="pubmed">27126039</ArticleId></ArticleIdList></Reference><Reference><Citation>King C.H., Desai H., Sylvetsky A.C., LoTempio J., Ayanyan S., Carrie J., Crandall K.A., Fochtman B.C., Gasparyan L., Gulzar N., et al. Baseline human gut microbiota profile in healthy people and standard reporting template. PLoS ONE. 2019;14:e0206484. doi: 10.1371/journal.pone.0206484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206484</ArticleId><ArticleId IdType="pmc">PMC6738582</ArticleId><ArticleId IdType="pubmed">31509535</ArticleId></ArticleIdList></Reference><Reference><Citation>Manor O., Dai C.L., Kornilov S.A., Smith B., Price N.D., Lovejoy J.C., Gibbons S.M., Magis A.T. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat. Commun. 2020;11:5206. doi: 10.1038/s41467-020-18871-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18871-1</ArticleId><ArticleId IdType="pmc">PMC7562722</ArticleId><ArticleId IdType="pubmed">33060586</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaiserman A., Romanenko M., Piven L., Moseiko V., Lushchak O., Kryzhanovska N., Guryanov V., Koliada A. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 2020;20:221. doi: 10.1186/s12866-020-01903-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-020-01903-7</ArticleId><ArticleId IdType="pmc">PMC7374892</ArticleId><ArticleId IdType="pubmed">32698765</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang D., Leung R.K.-K., Guan W., Au W.W. Involvement of gut microbiome in human health and disease: Brief overview, knowledge gaps and research opportunities. Gut Pathog. 2018;10:3. doi: 10.1186/s13099-018-0230-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-018-0230-4</ArticleId><ArticleId IdType="pmc">PMC5785832</ArticleId><ArticleId IdType="pubmed">29416567</ArticleId></ArticleIdList></Reference><Reference><Citation>Magne F., Gotteland M., Gauthier L., Zazueta A., Pesoa S., Navarrete P., Balamurugan R. The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? Nutrients. 2020;12:1474. doi: 10.3390/nu12051474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12051474</ArticleId><ArticleId IdType="pmc">PMC7285218</ArticleId><ArticleId IdType="pubmed">32438689</ArticleId></ArticleIdList></Reference><Reference><Citation>Knights D., Ward T.L., McKinlay C.E., Miller H., Gonzalez A., McDonald D., Knight R. Rethinking &#x201c;enterotypes&#x201d;. Cell Host Microbe. 2014;16:433&#x2013;437. doi: 10.1016/j.chom.2014.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.09.013</ArticleId><ArticleId IdType="pmc">PMC5558460</ArticleId><ArticleId IdType="pubmed">25299329</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirstea M., Radisavljevic N., Finlay B.B. Good bug, bad bug: Breaking through microbial stereotypes. Cell Host Microbe. 2018;23:10&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">29324224</ArticleId></ArticleIdList></Reference><Reference><Citation>Maskarinec G., Hullar M.A.J., Monroe K.R., Shepherd J.A., Hunt J., Randolph T.W., Wilkens L.R., Boushey C.J., Le Marchand L., Lim U., et al. Fecal Microbial Diversity and Structure Are Associated with Diet Quality in the Multiethnic Cohort Adiposity Phenotype Study. J. Nutr. 2019;149:1575&#x2013;1584. doi: 10.1093/jn/nxz065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxz065</ArticleId><ArticleId IdType="pmc">PMC6862930</ArticleId><ArticleId IdType="pubmed">31187868</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogal B., Blumberg J.B., Blander G., Jorge M. Gut Microbiota&#x2013;Informed Precision Nutrition in the Generally Healthy Individual: Are We There Yet? Curr. Dev. Nutr. 2021;5:nzab107. doi: 10.1093/cdn/nzab107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cdn/nzab107</ArticleId><ArticleId IdType="pmc">PMC8421235</ArticleId><ArticleId IdType="pubmed">34514287</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z. Gut Microbiota: An Important Link between Western Diet and Chronic Diseases. Nutrients. 2019;11:2287. doi: 10.3390/nu11102287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11102287</ArticleId><ArticleId IdType="pmc">PMC6835660</ArticleId><ArticleId IdType="pubmed">31554269</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., Collini S., Pieraccini G., Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA. 2010;107:14691&#x2013;14696. doi: 10.1073/pnas.1005963107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1005963107</ArticleId><ArticleId IdType="pmc">PMC2930426</ArticleId><ArticleId IdType="pubmed">20679230</ArticleId></ArticleIdList></Reference><Reference><Citation>Clooney A.G., Eckenberger J., Laserna-Mendieta E., Sexton K.A., Bernstein M.T., Vagianos K., Sargent M., Ryan F.J., Moran C., Sheehan D. Ranking microbiome variance in inflammatory bowel disease: A large longitudinal intercontinental study. Gut. 2021;70:499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873428</ArticleId><ArticleId IdType="pubmed">32536605</ArticleId></ArticleIdList></Reference><Reference><Citation>Metwaly A., Reitmeier S., Haller D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 2022;19:383&#x2013;397. doi: 10.1038/s41575-022-00581-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00581-2</ArticleId><ArticleId IdType="pubmed">35190727</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte L.A., Vich Vila A., Imhann F., Collij V., Gacesa R., Peters V., Wijmenga C., Kurilshikov A., Campmans-Kuijpers M.J.E., Fu J., et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut. 2021;70:1287&#x2013;1298. doi: 10.1136/gutjnl-2020-322670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322670</ArticleId><ArticleId IdType="pmc">PMC8223641</ArticleId><ArticleId IdType="pubmed">33811041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S., Moorthy M.V., Demler O.V., Hu F.B., Ridker P.M., Chasman D.I., Mora S. Assessment of Risk Factors and Biomarkers Associated With Risk of Cardiovascular Disease Among Women Consuming a Mediterranean Diet. JAMA Netw. Open. 2018;1:e185708. doi: 10.1001/jamanetworkopen.2018.5708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.5708</ArticleId><ArticleId IdType="pmc">PMC6324327</ArticleId><ArticleId IdType="pubmed">30646282</ArticleId></ArticleIdList></Reference><Reference><Citation>Guasch-Ferr&#xe9; M., Willett W.C. The Mediterranean diet and health: A comprehensive overview. J. Intern. Med. 2021;290:549&#x2013;566. doi: 10.1111/joim.13333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13333</ArticleId><ArticleId IdType="pubmed">34423871</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon O.M., Ranson J.M., Gregory S., Macpherson H., Milte C., Lentjes M., Mulligan A., McEvoy C., Griffiths A., Matu J., et al. Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: Findings from the UK Biobank prospective cohort study. BMC Med. 2023;21:81. doi: 10.1186/s12916-023-02772-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02772-3</ArticleId><ArticleId IdType="pmc">PMC10012551</ArticleId><ArticleId IdType="pubmed">36915130</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Q., Black A., Kales S.N., Vattem D., Ruiz-Canela M., Sotos-Prieto M. Metabolomics and microbiomes as potential tools to evaluate the effects of the Mediterranean diet. Nutrients. 2019;11:207. doi: 10.3390/nu11010207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11010207</ArticleId><ArticleId IdType="pmc">PMC6356665</ArticleId><ArticleId IdType="pubmed">30669673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomova A., Bukovsky I., Rembert E., Yonas W., Alwarith J., Barnard N.D., Kahleova H. The Effects of Vegetarian and Vegan Diets on Gut Microbiota. Front. Nutr. 2019;6:47. doi: 10.3389/fnut.2019.00047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2019.00047</ArticleId><ArticleId IdType="pmc">PMC6478664</ArticleId><ArticleId IdType="pubmed">31058160</ArticleId></ArticleIdList></Reference><Reference><Citation>So D., Loughman A., Staudacher H.M. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: A systematic review with meta-analysis. Am. J. Clin. Nutr. 2022;116:943&#x2013;952. doi: 10.1093/ajcn/nqac176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqac176</ArticleId><ArticleId IdType="pmc">PMC9535515</ArticleId><ArticleId IdType="pubmed">35728042</ArticleId></ArticleIdList></Reference><Reference><Citation>Engen P.A., Green S.J., Voigt R.M., Forsyth C.B., Keshavarzian A. The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota. Alcohol. Res. 2015;37:223&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590619</ArticleId><ArticleId IdType="pubmed">26695747</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijay A., Kouraki A., Gohir S., Turnbull J., Kelly A., Chapman V., Barrett D.A., Bulsiewicz W.J., Valdes A.M. The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids. Gut Microbes. 2021;13:1997559. doi: 10.1080/19490976.2021.1997559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1997559</ArticleId><ArticleId IdType="pmc">PMC8604388</ArticleId><ArticleId IdType="pubmed">34787065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J.-H., Kim C.-S., Cha L., Kim S., Lee S., Chae S., Chun W.Y., Shin D.-M. Consumption of 85% cocoa dark chocolate improves mood in association with gut microbial changes in healthy adults: A randomized controlled trial. J. Nutr. Biochem. 2022;99:108854.</Citation><ArticleIdList><ArticleId IdType="pubmed">34530112</ArticleId></ArticleIdList></Reference><Reference><Citation>Camps-Bossacoma M., Massot-Cladera M., P&#xe9;rez-Cano F.J., Castell M. Chapter 18-Influence of a Cocoa-Enriched Diet on the Intestinal Immune System and Microbiota. In: Watson R.R., Preedy V.R., editors. Dietary Interventions in Gastrointestinal Diseases. Academic Press; Cambridge, MA, USA: 2019. pp. 213&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-814468-8.00018-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivakoti R., Biggs M.L., Djouss&#xe9; L., Durda P.J., Kizer J.R., Psaty B., Reiner A.P., Tracy R.P., Siscovick D., Mukamal K.J. Intake and Sources of Dietary Fiber, Inflammation, and Cardiovascular Disease in Older US Adults. JAMA Netw. Open. 2022;5:e225012. doi: 10.1001/jamanetworkopen.2022.5012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.5012</ArticleId><ArticleId IdType="pmc">PMC8972036</ArticleId><ArticleId IdType="pubmed">35357453</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta S., Johansson A., Drake I. Diet and Lifestyle Factors and Risk of Atherosclerotic Cardiovascular Disease&#x2014;A Prospective Cohort Study. Nutrients. 2021;13:3822. doi: 10.3390/nu13113822.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113822</ArticleId><ArticleId IdType="pmc">PMC8622601</ArticleId><ArticleId IdType="pubmed">34836078</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyr&#xf8; C., Tj&#xf8;nneland A., Overvad K., Olsen A., Landberg R. Higher Whole-Grain Intake Is Associated with Lower Risk of Type 2 Diabetes among Middle-Aged Men and Women: The Danish Diet, Cancer, and Health Cohort. J. Nutr. 2018;148:1434&#x2013;1444. doi: 10.1093/jn/nxy112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxy112</ArticleId><ArticleId IdType="pubmed">30016529</ArticleId></ArticleIdList></Reference><Reference><Citation>Da&#xef;en C.I., Pinget G.V., Tan J.K., Macia L. Detrimental Impact of Microbiota-Accessible Carbohydrate-Deprived Diet on Gut and Immune Homeostasis: An Overview. Front. Immunol. 2017;8:548. doi: 10.3389/fimmu.2017.00548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00548</ArticleId><ArticleId IdType="pmc">PMC5427073</ArticleId><ArticleId IdType="pubmed">28553291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenburg E.D., Sonnenburg J.L. Starving our Microbial Self: The Deleterious Consequences of a Diet Deficient in Microbiota-Accessible Carbohydrates. Cell Metab. 2014;20:779&#x2013;786. doi: 10.1016/j.cmet.2014.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.07.003</ArticleId><ArticleId IdType="pmc">PMC4896489</ArticleId><ArticleId IdType="pubmed">25156449</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenaar C.A., van de Put M., Bisschops M., Walrabenstein W., de Jonge C.S., Herrema H., van Schaardenburg D. The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review. Nutrients. 2021;13:3208. doi: 10.3390/nu13093208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13093208</ArticleId><ArticleId IdType="pmc">PMC8464906</ArticleId><ArticleId IdType="pubmed">34579085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin K.H., Rasmussen N.F., Petersen I., Kopp T.I., Stenager E., Magyari M., Hetland M.L., Bygum A., Glintborg B., Andersen V. Intake of dietary fibre, red and processed meat and risk of late-onset Chronic Inflammatory Diseases: A prospective Danish study on the &#x201c;diet, cancer and health&#x201d; cohort. Int. J. Med. Sci. 2020;17:2487&#x2013;2495. doi: 10.7150/ijms.49314.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.49314</ArticleId><ArticleId IdType="pmc">PMC7532485</ArticleId><ArticleId IdType="pubmed">33029091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford A.L., Nagulesapillai V., Piano A., Auger J., Girard S.-A., Christman M., Tompkins T.A., Dahl W.J. Microbiota stability and gastrointestinal tolerance in response to a high-protein diet with and without a prebiotic, probiotic, and synbiotic: A randomized, double-blind, placebo-controlled trial in older women. J. Acad. Nutr. Diet. 2020;120:500&#x2013;516.e10. doi: 10.1016/j.jand.2019.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jand.2019.12.009</ArticleId><ArticleId IdType="pubmed">32199523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N., Tian Y., Wu Y., Ma X. Contributions of the Interaction Between Dietary Protein and Gut Microbiota to Intestinal Health. Curr. Protein Pept. Sci. 2017;18:795&#x2013;808. doi: 10.2174/1389203718666170216153505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203718666170216153505</ArticleId><ArticleId IdType="pubmed">28215168</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Chen Z., Wu W., Lin Q., Liang Y. High animal protein diet and gut microbiota in human health. Crit. Rev. Food Sci. Nutr. 2022;62:6225&#x2013;6237. doi: 10.1080/10408398.2021.1898336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2021.1898336</ArticleId><ArticleId IdType="pubmed">33724115</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy E.A., Velazquez K.T., Herbert K.M. Influence of high-fat diet on gut microbiota: A driving force for chronic disease risk. Curr. Opin. Clin. Nutr. Metab. Care. 2015;18:515&#x2013;520. doi: 10.1097/MCO.0000000000000209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000209</ArticleId><ArticleId IdType="pmc">PMC4578152</ArticleId><ArticleId IdType="pubmed">26154278</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y., Wang F., Yuan J., Li J., Jiang D., Zhang J., Li H., Wang R., Tang J., Huang T., et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: A 6-month randomised controlled-feeding trial. Gut. 2019;68:1417&#x2013;1429. doi: 10.1136/gutjnl-2018-317609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-317609</ArticleId><ArticleId IdType="pubmed">30782617</ArticleId></ArticleIdList></Reference><Reference><Citation>Satokari R. High Intake of Sugar and the Balance between Pro- and Anti-Inflammatory Gut Bacteria. Nutrients. 2020;12:1348. doi: 10.3390/nu12051348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12051348</ArticleId><ArticleId IdType="pmc">PMC7284805</ArticleId><ArticleId IdType="pubmed">32397233</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson C.A., Vuong H.E., Yano J.M., Liang Q.Y., Nusbaum D.J., Hsiao E.Y. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018;173:1728&#x2013;1741.e13. doi: 10.1016/j.cell.2018.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.04.027</ArticleId><ArticleId IdType="pmc">PMC6003870</ArticleId><ArticleId IdType="pubmed">29804833</ArticleId></ArticleIdList></Reference><Reference><Citation>Basciani S., Camajani E., Contini S., Persichetti A., Risi R., Bertoldi L., Strigari L., Prossomariti G., Watanabe M., Mariani S. Very-low-calorie ketogenic diets with whey, vegetable, or animal protein in patients with obesity: A randomized pilot study. J. Clin. Endocrinol. Metab. 2020;105:2939&#x2013;2949. doi: 10.1210/clinem/dgaa336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa336</ArticleId><ArticleId IdType="pubmed">32484877</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L.B., Zhang Y.C., Huang H.H., Lin J. Prospects for clinical applications of butyrate-producing bacteria. World J. Clin. Pediatr. 2021;10:84&#x2013;92. doi: 10.5409/wjcp.v10.i5.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.5409/wjcp.v10.i5.84</ArticleId><ArticleId IdType="pmc">PMC8465514</ArticleId><ArticleId IdType="pubmed">34616650</ArticleId></ArticleIdList></Reference><Reference><Citation>Elce A., Amato F., Zarrilli F., Calignano A., Troncone R., Castaldo G., Canani R. Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells. Benef. Microbes. 2017;8:841&#x2013;847. doi: 10.3920/BM2016.0197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2016.0197</ArticleId><ArticleId IdType="pubmed">28856908</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Beek C.M., Dejong C.H., Troost F.J., Masclee A.A., Lenaerts K. Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing. Nutr. Rev. 2017;75:286&#x2013;305. doi: 10.1093/nutrit/nuw067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuw067</ArticleId><ArticleId IdType="pubmed">28402523</ArticleId></ArticleIdList></Reference><Reference><Citation>Krautkramer K.A., Fan J., B&#xe4;ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat. Rev. Microbiol. 2021;19:77&#x2013;94. doi: 10.1038/s41579-020-0438-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-0438-4</ArticleId><ArticleId IdType="pubmed">32968241</ArticleId></ArticleIdList></Reference><Reference><Citation>Larabi A.B., Masson H.L., B&#xe4;umler A.J. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023;15:2172671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9904317</ArticleId><ArticleId IdType="pubmed">36740850</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorucci S., Biagioli M., Zampella A., Distrutti E. Bile acids activated receptors regulate innate immunity. Front. Immunol. 2018;9:1853. doi: 10.3389/fimmu.2018.01853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01853</ArticleId><ArticleId IdType="pmc">PMC6099188</ArticleId><ArticleId IdType="pubmed">30150987</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre A.M., Yalcinkaya N., Wu Q., Swennes A., Tessier M.E., Roberts P., Miyajima F., Savidge T., Sorg J.A. Bile acid-independent protection against Clostridioides difficile infection. PLoS Pathog. 2021;17:e1010015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8555850</ArticleId><ArticleId IdType="pubmed">34665847</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghoubfar R., Behrouzi A., Ashrafian F., Shahryari A., Moradi H.R., Choopani S., Hadifar S., Vaziri F., Nojoumi S.A., Fateh A. Modulation of serotonin signaling/metabolism by Akkermansia muciniphila and its extracellular vesicles through the gut-brain axis in mice. Sci. Rep. 2020;10:22119. doi: 10.1038/s41598-020-79171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79171-8</ArticleId><ArticleId IdType="pmc">PMC7747642</ArticleId><ArticleId IdType="pubmed">33335202</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasova L., Grman M., Ondrias K., Ufnal M. The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health. Nutr. Metab. 2021;18:72. doi: 10.1186/s12986-021-00598-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12986-021-00598-5</ArticleId><ArticleId IdType="pmc">PMC8281717</ArticleId><ArticleId IdType="pubmed">34266472</ArticleId></ArticleIdList></Reference><Reference><Citation>Varesi A., Pierella E., Romeo M., Piccini G.B., Alfano C., Bj&#xf8;rklund G., Oppong A., Ricevuti G., Esposito C., Chirumbolo S., et al. The Potential Role of Gut Microbiota in Alzheimer&#x2019;s Disease: From Diagnosis to Treatment. Nutrients. 2022;14:668. doi: 10.3390/nu14030668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14030668</ArticleId><ArticleId IdType="pmc">PMC8840394</ArticleId><ArticleId IdType="pubmed">35277027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon M.D., Tack J. The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397&#x2013;414. doi: 10.1053/j.gastro.2006.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2006.11.002</ArticleId><ArticleId IdType="pubmed">17241888</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennoune N., Andriamihaja M., Blachier F. Production of Indole and Indole-Related Compounds by the Intestinal Microbiota and Consequences for the Host: The Good, the Bad, and the Ugly. Microorganisms. 2022;10:930. doi: 10.3390/microorganisms10050930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10050930</ArticleId><ArticleId IdType="pmc">PMC9145683</ArticleId><ArticleId IdType="pubmed">35630374</ArticleId></ArticleIdList></Reference><Reference><Citation>Benech N., Rolhion N., Sokol H. Tryptophan metabolites get the gut moving. Cell Host Microbe. 2021;29:145&#x2013;147. doi: 10.1016/j.chom.2021.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.01.009</ArticleId><ArticleId IdType="pubmed">33571438</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajsl M., Hlavackova A., Broulikova K., Sramek M., Maly M., Dyr J.E., Suttnar J. Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease. Metabolites. 2020;10:208. doi: 10.3390/metabo10050208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10050208</ArticleId><ArticleId IdType="pmc">PMC7281607</ArticleId><ArticleId IdType="pubmed">32438592</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin R., Kaiser K.A., de los Santos-Alexis K., Park H., Uhlemann A.-C., DHD G., Arpaia N. Dietary tryptophan deficiency promotes gut RORgt+ Treg cells at the expense of Gata3+ Treg cells and alters commensal microbiota metabolism. Cell Rep. 2023;42:112135. doi: 10.1016/j.celrep.2023.112135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112135</ArticleId><ArticleId IdType="pmc">PMC10150404</ArticleId><ArticleId IdType="pubmed">36840944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawley T.D., Walker A.W. Intestinal colonization resistance. Immunology. 2013;138:1&#x2013;11. doi: 10.1111/j.1365-2567.2012.03616.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2012.03616.x</ArticleId><ArticleId IdType="pmc">PMC3533696</ArticleId><ArticleId IdType="pubmed">23240815</ArticleId></ArticleIdList></Reference><Reference><Citation>Glover J.S., Ticer T.D., Engevik M.A. Characterizing the mucin-degrading capacity of the human gut microbiota. Sci. Rep. 2022;12:8456. doi: 10.1038/s41598-022-11819-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11819-z</ArticleId><ArticleId IdType="pmc">PMC9120202</ArticleId><ArticleId IdType="pubmed">35589783</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito Y., Uchiyama K., Takagi T. A next-generation beneficial microbe: Akkermansia muciniphila. J. Clin. Biochem. Nutr. 2018;63:33&#x2013;35. doi: 10.3164/jcbn.18-57.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.18-57</ArticleId><ArticleId IdType="pmc">PMC6064808</ArticleId><ArticleId IdType="pubmed">30087541</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinoso Webb C., Koboziev I., Furr K.L., Grisham M.B. Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology. 2016;23:67&#x2013;80. doi: 10.1016/j.pathophys.2016.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pathophys.2016.02.002</ArticleId><ArticleId IdType="pmc">PMC4867289</ArticleId><ArticleId IdType="pubmed">26947707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiertsema S.P., van Bergenhenegouwen J., Garssen J., Knippels L.M.J. The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. Nutrients. 2021;13:886. doi: 10.3390/nu13030886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13030886</ArticleId><ArticleId IdType="pmc">PMC8001875</ArticleId><ArticleId IdType="pubmed">33803407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D., Liwinski T., Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492&#x2013;506. doi: 10.1038/s41422-020-0332-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0332-7</ArticleId><ArticleId IdType="pmc">PMC7264227</ArticleId><ArticleId IdType="pubmed">32433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Gensollen T., Iyer S.S., Kasper D.L., Blumberg R.S. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539&#x2013;544. doi: 10.1126/science.aad9378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad9378</ArticleId><ArticleId IdType="pmc">PMC5050524</ArticleId><ArticleId IdType="pubmed">27126036</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi N., Li N., Duan X., Niu H. Interaction between the gut microbiome and mucosal immune system. Mil. Med. Res. 2017;4:14. doi: 10.1186/s40779-017-0122-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-017-0122-9</ArticleId><ArticleId IdType="pmc">PMC5408367</ArticleId><ArticleId IdType="pubmed">28465831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly J.R., Kennedy P.J., Cryan J.F., Dinan T.G., Clarke G., Hyland N.P. Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front. Cell. Neurosci. 2015;9:392. doi: 10.3389/fncel.2015.00392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00392</ArticleId><ArticleId IdType="pmc">PMC4604320</ArticleId><ArticleId IdType="pubmed">26528128</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffington S.A., Dooling S.W., Sgritta M., Noecker C., Murillo O.D., Felice D.F., Turnbaugh P.J., Costa-Mattioli M. Dissecting the contribution of host genetics and the microbiome in complex behaviors. Cell. 2021;184:1740&#x2013;1756.e16. doi: 10.1016/j.cell.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC8996745</ArticleId><ArticleId IdType="pubmed">33705688</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Xu J., Ling Y., Wang F., Gong T., Yang C., Ye S., Ye K., Wei D., Song Z., et al. Fecal microbiota transplantation alleviated Alzheimer&#x2019;s disease-like pathogenesis in APP/PS1 transgenic mice. Transl. Psychiatry. 2019;9:189. doi: 10.1038/s41398-019-0525-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0525-3</ArticleId><ArticleId IdType="pmc">PMC6683152</ArticleId><ArticleId IdType="pubmed">31383855</ArticleId></ArticleIdList></Reference><Reference><Citation>Suganya K., Koo B.S. Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. Int. J. Mol. Sci. 2020;21:7551. doi: 10.3390/ijms21207551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21207551</ArticleId><ArticleId IdType="pmc">PMC7589356</ArticleId><ArticleId IdType="pubmed">33066156</ArticleId></ArticleIdList></Reference><Reference><Citation>Treangen T.J., Wagner J., Burns M.P., Villapol S. Traumatic brain injury in mice induces acute bacterial dysbiosis within the fecal microbiome. Front. Immunol. 2018;9:2757. doi: 10.3389/fimmu.2018.02757.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02757</ArticleId><ArticleId IdType="pmc">PMC6278748</ArticleId><ArticleId IdType="pubmed">30546361</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz Heijtz R., Wang S., Anuar F., Qian Y., Bj&#xf6;rkholm B., Samuelsson A., Hibberd M.L., Forssberg H., Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA. 2011;108:3047&#x2013;3052. doi: 10.1073/pnas.1010529108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010529108</ArticleId><ArticleId IdType="pmc">PMC3041077</ArticleId><ArticleId IdType="pubmed">21282636</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA. 2011;108:16050&#x2013;16055. doi: 10.1073/pnas.1102999108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102999108</ArticleId><ArticleId IdType="pmc">PMC3179073</ArticleId><ArticleId IdType="pubmed">21876150</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgritta M., Dooling S.W., Buffington S.A., Momin E.N., Francis M.B., Britton R.A., Costa-Mattioli M. Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron. 2019;101:246&#x2013;259.e6. doi: 10.1016/j.neuron.2018.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.11.018</ArticleId><ArticleId IdType="pmc">PMC6645363</ArticleId><ArticleId IdType="pubmed">30522820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers G., Keating D.J., Young R.L., Wong M.-L., Licinio J., Wesselingh S. From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol. Psychiatry. 2016;21:738&#x2013;748. doi: 10.1038/mp.2016.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.50</ArticleId><ArticleId IdType="pmc">PMC4879184</ArticleId><ArticleId IdType="pubmed">27090305</ArticleId></ArticleIdList></Reference><Reference><Citation>Labanski A., Langhorst J., Engler H., Elsenbruch S. Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: A transdisciplinary challenge. Psychoneuroendocrinology. 2020;111:104501. doi: 10.1016/j.psyneuen.2019.104501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2019.104501</ArticleId><ArticleId IdType="pubmed">31715444</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider K.M., Blank N., Alvarez Y., Thum K., Lundgren P., Litichevskiy L., Sleeman M., Bahnsen K., Kim J., Kardo S., et al. The enteric nervous system relays psychological stress to intestinal inflammation. Cell. 2023;186:1&#x2013;16. doi: 10.1016/j.cell.2023.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.05.001</ArticleId><ArticleId IdType="pmc">PMC10330875</ArticleId><ArticleId IdType="pubmed">37236193</ArticleId></ArticleIdList></Reference><Reference><Citation>Almand A.T., Anderson A.P., Hitt B.D., Sitko J.C., Joy R.M., Easter B.D., Almand E.A. The influence of perceived stress on the human microbiome. BMC Res. Notes. 2022;15:193. doi: 10.1186/s13104-022-06066-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-022-06066-4</ArticleId><ArticleId IdType="pmc">PMC9164568</ArticleId><ArticleId IdType="pubmed">35659718</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-J., Lin C.-H. Gut microenvironmental changes as a potential trigger in Parkinson&#x2019;s disease through the gut&#x2013;brain axis. J. Biomed. Sci. 2022;29:54. doi: 10.1186/s12929-022-00839-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-022-00839-6</ArticleId><ArticleId IdType="pmc">PMC9327249</ArticleId><ArticleId IdType="pubmed">35897024</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavan S.S., Pavlov V.A., Tracey K.J. Mechanisms and Therapeutic Relevance of Neuro-immune Communication. Immunity. 2017;46:927&#x2013;942. doi: 10.1016/j.immuni.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5578398</ArticleId><ArticleId IdType="pubmed">28636960</ArticleId></ArticleIdList></Reference><Reference><Citation>Calarge C.A., Devaraj S., Shulman R.J. Gut permeability and depressive symptom severity in unmedicated adolescents. J. Affect. Disord. 2019;246:586&#x2013;594. doi: 10.1016/j.jad.2018.12.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2018.12.077</ArticleId><ArticleId IdType="pubmed">30605877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaz B., Bazin T., Pellissier S. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front. Neurosci. 2018;12:49. doi: 10.3389/fnins.2018.00049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00049</ArticleId><ArticleId IdType="pmc">PMC5808284</ArticleId><ArticleId IdType="pubmed">29467611</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W., Zhu H., Feng Y., Guo R., Wan D. The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier. Infect. Drug Resist. 2020;13:3351&#x2013;3363. doi: 10.2147/IDR.S254403.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S254403</ArticleId><ArticleId IdType="pmc">PMC7532923</ArticleId><ArticleId IdType="pubmed">33061482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Keogh J., Clifton P. Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr. Res. Rev. 2018;31:35&#x2013;51. doi: 10.1017/S095442241700018X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S095442241700018X</ArticleId><ArticleId IdType="pubmed">29037268</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzi A., Fr&#xf6;hlich E.E., Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15:5&#x2013;22. doi: 10.1007/s13311-017-0600-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-017-0600-5</ArticleId><ArticleId IdType="pmc">PMC5794709</ArticleId><ArticleId IdType="pubmed">29380303</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Li Y., Zhang Q., Song Y., Wang L., Zhu Z. Interactions Between Intestinal Microbiota and Neural Mitochondria: A New Perspective on Communicating Pathway From Gut to Brain. Front. Microbiol. 2022;13:798917. doi: 10.3389/fmicb.2022.798917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.798917</ArticleId><ArticleId IdType="pmc">PMC8908256</ArticleId><ArticleId IdType="pubmed">35283843</ArticleId></ArticleIdList></Reference><Reference><Citation>Borre Y.E., O&#x2019;Keeffe G.W., Clarke G., Stanton C., Dinan T.G., Cryan J.F. Microbiota and neurodevelopmental windows: Implications for brain disorders. Trends Mol. Med. 2014;20:509&#x2013;518. doi: 10.1016/j.molmed.2014.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2014.05.002</ArticleId><ArticleId IdType="pubmed">24956966</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan J.F., O&#x2019;Riordan K.J., Sandhu K., Peterson V., Dinan T.G. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19:179&#x2013;194. doi: 10.1016/S1474-4422(19)30356-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30356-4</ArticleId><ArticleId IdType="pubmed">31753762</ArticleId></ArticleIdList></Reference><Reference><Citation>Luczynski P., Whelan S.O., O&#x2019;Sullivan C., Clarke G., Shanahan F., Dinan T.G., Cryan J.F. Adult microbiota-deficient mice have distinct dendritic morphological changes: Differential effects in the amygdala and hippocampus. Eur. J. Neurosci. 2016;44:2654&#x2013;2666. doi: 10.1111/ejn.13291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13291</ArticleId><ArticleId IdType="pmc">PMC5113767</ArticleId><ArticleId IdType="pubmed">27256072</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins J., Borojevic R., Verdu E., Huizinga J., Ratcliffe E. Intestinal microbiota influence the early postnatal development of the enteric nervous system. Neurogastroenterol. Motil. 2014;26:98&#x2013;107. doi: 10.1111/nmo.12236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12236</ArticleId><ArticleId IdType="pubmed">24329946</ArticleId></ArticleIdList></Reference><Reference><Citation>de Weerth C. Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis. Neurosci. Biobehav. Rev. 2017;83:458&#x2013;471. doi: 10.1016/j.neubiorev.2017.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.09.016</ArticleId><ArticleId IdType="pubmed">28918360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cussotto S., Sandhu K.V., Dinan T.G., Cryan J.F. The neuroendocrinology of the microbiota-gut-brain axis: A behavioural perspective. Front. Neuroendocrinol. 2018;51:80&#x2013;101. doi: 10.1016/j.yfrne.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2018.04.002</ArticleId><ArticleId IdType="pubmed">29753796</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniya M.A., Chung H.J., Al Mamun A., Alam S., Aziz M., Emon N.U., Islam M., Hong S.S., Podder B.R., Ara Mimi A., et al. Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation. Front. Cell Infect. Microbiol. 2022;12:998. doi: 10.3389/fcimb.2022.915701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.915701</ArticleId><ArticleId IdType="pmc">PMC9355470</ArticleId><ArticleId IdType="pubmed">35937689</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiani F., Cornuti S., Tognini P. The gut-brain connection: Exploring the influence of the gut microbiota on neuroplasticity and neurodevelopmental disorders. Neuropharmacology. 2023;231:109491. doi: 10.1016/j.neuropharm.2023.109491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2023.109491</ArticleId><ArticleId IdType="pubmed">36924923</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L. The microbiome and risk for obesity and diabetes. Jama. 2017;317:355&#x2013;356. doi: 10.1001/jama.2016.20099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.20099</ArticleId><ArticleId IdType="pubmed">28006047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.J., Sears C.L., Maruthur N. Gut microbiome and its role in obesity and insulin resistance. Ann. N. Y. Acad. Sci. 2020;1461:37&#x2013;52. doi: 10.1111/nyas.14107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14107</ArticleId><ArticleId IdType="pubmed">31087391</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassner K.L., Abraham B.P., Quigley E.M. The microbiome and inflammatory bowel disease. J. Allergy Clin. Immunol. 2020;145:16&#x2013;27. doi: 10.1016/j.jaci.2019.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.11.003</ArticleId><ArticleId IdType="pubmed">31910984</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan I., Ullah N., Zha L., Bai Y., Khan A., Zhao T., Che T., Zhang C. Alteration of gut microbiota in inflammatory bowel disease (IBD): Cause or consequence? IBD treatment targeting the gut microbiome. Pathogens. 2019;8:126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6789542</ArticleId><ArticleId IdType="pubmed">31412603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Chang E.B. Inflammatory Bowel Diseases (IBD) and the microbiome&#x2014;Searching the crime scene for clues. Gastroenterology. 2021;160:524&#x2013;537. doi: 10.1053/j.gastro.2020.09.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.09.056</ArticleId><ArticleId IdType="pmc">PMC8098834</ArticleId><ArticleId IdType="pubmed">33253681</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P.P., Chin V.K., Looi C.Y., Wong W.F., Madhavan P., Yong V.C. The microbiome and irritable bowel syndrome&#x2013;a review on the pathophysiology, current research and future therapy. Front. Microbiol. 2019;10:1136. doi: 10.3389/fmicb.2019.01136.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01136</ArticleId><ArticleId IdType="pmc">PMC6579922</ArticleId><ArticleId IdType="pubmed">31244784</ArticleId></ArticleIdList></Reference><Reference><Citation>Menees S., Chey W. The gut microbiome and irritable bowel syndrome. F1000Research. 2018;7:1029. doi: 10.12688/f1000research.14592.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.14592.1</ArticleId><ArticleId IdType="pmc">PMC6039952</ArticleId><ArticleId IdType="pubmed">30026921</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Chang Y., Zhang K., Chen H., Tao S., Zhang Z. Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Sci. Rep. 2020;10:5450. doi: 10.1038/s41598-020-62224-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62224-3</ArticleId><ArticleId IdType="pmc">PMC7096501</ArticleId><ArticleId IdType="pubmed">32214153</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabke K., Hendrick G., Devkota S. The gut microbiome and metabolic syndrome. J. Clin. Investig. 2019;129:4050&#x2013;4057. doi: 10.1172/JCI129194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI129194</ArticleId><ArticleId IdType="pmc">PMC6763239</ArticleId><ArticleId IdType="pubmed">31573550</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Tripathi P. Gut microbiome and type 2 diabetes: Where we are and where to go? J. Nutr. Biochem. 2019;63:101&#x2013;108. doi: 10.1016/j.jnutbio.2018.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2018.10.003</ArticleId><ArticleId IdType="pubmed">30366260</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer-Englar T., Barlow G., Mathur R. Obesity, diabetes, and the gut microbiome: An updated review. Expert Rev. Gastroenterol. Hepatol. 2019;13:3&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">30791839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu T., Goodarzi M.O. Metabolites linking the gut microbiome with risk for type 2 diabetes. Curr. Nutr. Rep. 2020;9:83&#x2013;93. doi: 10.1007/s13668-020-00307-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-020-00307-3</ArticleId><ArticleId IdType="pmc">PMC7282969</ArticleId><ArticleId IdType="pubmed">32157661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikalidis A.K., Maykish A. The Gut Microbiome and Type 2 Diabetes Mellitus: Discussing A Complex Relationship. Biomedicines. 2020;8:8. doi: 10.3390/biomedicines8010008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8010008</ArticleId><ArticleId IdType="pmc">PMC7168169</ArticleId><ArticleId IdType="pubmed">31936158</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodkhe R., Balakrishnan B., Taneja V. The role of microbiome in rheumatoid arthritis treatment. Adv. Musculoskelet. Dis. 2019;11:1759720x19844632. doi: 10.1177/1759720X19844632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X19844632</ArticleId><ArticleId IdType="pmc">PMC6685117</ArticleId><ArticleId IdType="pubmed">31431810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Goel R., Kumar A., Qi Y., Lobaton G., Hosaka K., Mohammed M., Handberg E.M., Richards E.M., Pepine C.J., et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin. Sci. 2018;132:701&#x2013;718. doi: 10.1042/CS20180087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180087</ArticleId><ArticleId IdType="pmc">PMC5955695</ArticleId><ArticleId IdType="pubmed">29507058</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., Qian Z., Yin J., Xu W., Zhou X. The role of intestinal microbiota in cardiovascular disease. J. Cell. Mol. Med. 2019;23:2343&#x2013;2350. doi: 10.1111/jcmm.14195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14195</ArticleId><ArticleId IdType="pmc">PMC6433673</ArticleId><ArticleId IdType="pubmed">30712327</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J., Xiao X., Hu M., Zhang X. Interaction between gut microbiome and cardiovascular disease. Life Sci. 2018;214:153&#x2013;157. doi: 10.1016/j.lfs.2018.10.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.10.063</ArticleId><ArticleId IdType="pubmed">30385177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida N., Yamashita T., Hirata K.-i. Gut microbiome and cardiovascular diseases. Diseases. 2018;6:56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6164700</ArticleId><ArticleId IdType="pubmed">29966270</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.W., Kitai T., Hazen S.L. Gut microbiota in cardiovascular health and disease. Circ. Res. 2017;120:1183&#x2013;1196. doi: 10.1161/CIRCRESAHA.117.309715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.309715</ArticleId><ArticleId IdType="pmc">PMC5390330</ArticleId><ArticleId IdType="pubmed">28360349</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Wang H., Xu S., Zhuang Y., An J., Su C., Xia Y., Chen J., Xu Z.Z., Liu Q., et al. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes. 2020;11:1758&#x2013;1773. doi: 10.1080/19490976.2020.1768644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1768644</ArticleId><ArticleId IdType="pmc">PMC7524333</ArticleId><ArticleId IdType="pubmed">32507008</ArticleId></ArticleIdList></Reference><Reference><Citation>Safari Z., G&#xe9;rard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD) Cell. Mol. Life Sci. 2019;76:1541&#x2013;1558. doi: 10.1007/s00018-019-03011-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03011-w</ArticleId><ArticleId IdType="pmc">PMC11105223</ArticleId><ArticleId IdType="pubmed">30683985</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosicki G.J., Fielding R.A., Lustgarten M.S. Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis. Calcif. Tissue Int. 2018;102:433&#x2013;442. doi: 10.1007/s00223-017-0345-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-017-0345-5</ArticleId><ArticleId IdType="pmc">PMC5858871</ArticleId><ArticleId IdType="pubmed">29058056</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati M., Ferri E., Azzolino D., Cesari M., Arosio B. Gut microbiota and physical frailty through the mediation of sarcopenia. Exp. Gerontol. 2019;124:110639. doi: 10.1016/j.exger.2019.110639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2019.110639</ArticleId><ArticleId IdType="pubmed">31226349</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclercq S., Matamoros S., Cani P.D., Neyrinck A.M., Jamar F., St&#xe4;rkel P., Windey K., Tremaroli V., B&#xe4;ckhed F., Verbeke K. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. USA. 2014;111:E4485&#x2013;E4493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4210345</ArticleId><ArticleId IdType="pubmed">25288760</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuco A., Urits I., Hasoon J., Chun R., Gerald B., Wang J.K., Kassem H., Ngo A.L., Abd-Elsayed A., Simopoulos T., et al. Current Perspectives on Gut Microbiome Dysbiosis and Depression. Adv. Ther. 2020;37:1328&#x2013;1346. doi: 10.1007/s12325-020-01272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-020-01272-7</ArticleId><ArticleId IdType="pmc">PMC7140737</ArticleId><ArticleId IdType="pubmed">32130662</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson C.A., Diaz-Arteche C., Eliby D., Schwartz O.S., Simmons J.G., Cowan C.S.M. The gut microbiota in anxiety and depression&#x2013;A systematic review. Clin. Psychol. Rev. 2021;83:101943. doi: 10.1016/j.cpr.2020.101943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2020.101943</ArticleId><ArticleId IdType="pubmed">33271426</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Wei J., Ju P., Chen J. Effects of regulating intestinal microbiota on anxiety symptoms: A systematic review. Gen. Psychiatr. 2019;32:e100056. doi: 10.1136/gpsych-2019-100056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gpsych-2019-100056</ArticleId><ArticleId IdType="pmc">PMC6551444</ArticleId><ArticleId IdType="pubmed">31179435</ArticleId></ArticleIdList></Reference><Reference><Citation>Arzani M., Jahromi S.R., Ghorbani Z., Vahabizad F., Martelletti P., Ghaemi A., Sacco S., Togha M., School of Advanced Studies of the European Headache Federation (EHF-SAS) Gut-brain axis and migraine headache: A comprehensive review. J. Headache Pain. 2020;21:15. doi: 10.1186/s10194-020-1078-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-1078-9</ArticleId><ArticleId IdType="pmc">PMC7020496</ArticleId><ArticleId IdType="pubmed">32054443</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoubridge A.P., Choo J.M., Martin A.M., Keating D.J., Wong M.-L., Licinio J., Rogers G.B. The gut microbiome and mental health: Advances in research and emerging priorities. Mol. Psychiatry. 2022;27:1908&#x2013;1919. doi: 10.1038/s41380-022-01479-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01479-w</ArticleId><ArticleId IdType="pubmed">35236957</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X., Gu X., Zhou X., Chen X., Zhang X., Yang Y., Qin Y., Shen L., Yu W., Su D. Intestinal dysbacteriosis mediates the reference memory deficit induced by anaesthesia/surgery in aged mice. Brain Behav. Immun. 2019;80:605&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">31063849</ArticleId></ArticleIdList></Reference><Reference><Citation>Panther E.J., Dodd W., Clark A., Lucke-Wold B. Gastrointestinal microbiome and neurologic injury. Biomedicines. 2022;10:500. doi: 10.3390/biomedicines10020500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020500</ArticleId><ArticleId IdType="pmc">PMC8962360</ArticleId><ArticleId IdType="pubmed">35203709</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng C., Deng P., Miao R., Tang H., Li Y., Wang J., Wu J., Wang W., Liu S., Xia J., et al. Gut Microbiome and Risk of Ischemic Stroke: A Comprehensive Mendelian Randomization Study. Eur. J. Prev. Cardiol. 2023;30:613&#x2013;620. doi: 10.1093/eurjpc/zwad052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwad052</ArticleId><ArticleId IdType="pubmed">36799937</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger J.C. Role of Inflammation in Depression and Treatment Implications. Handb. Exp. Pharm. 2019;250:255&#x2013;286. doi: 10.1007/164_2018_166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/164_2018_166</ArticleId><ArticleId IdType="pubmed">30368652</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bhattarai S.K., Foley S.E., Dutta P., Ward D.V., Bucci V., McCormick B.A. Alzheimer&#x2019;s disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway. mBio. 2019;10:e00632-19. doi: 10.1128/mBio.00632-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00632-19</ArticleId><ArticleId IdType="pmc">PMC6509190</ArticleId><ArticleId IdType="pubmed">31064831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasser C.I., Mercieca E.-C., Kong G., Hannan A.J., McKeown S.J., Glikmann-Johnston Y., Stout J.C. Gut dysbiosis in Huntington&#x2019;s disease: Associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun. 2020;2:fcaa110. doi: 10.1093/braincomms/fcaa110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa110</ArticleId><ArticleId IdType="pmc">PMC7519724</ArticleId><ArticleId IdType="pubmed">33005892</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumitrescu L., Marta D., D&#x103;n&#x103;u A., Lefter A., Tulb&#x103; D., Cozma L., Manole E., Gherghiceanu M., Ceafalan L.C., Popescu B.O. Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson&#x2019;s disease. Front. Neurosci. 2021;15:689723. doi: 10.3389/fnins.2021.689723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.689723</ArticleId><ArticleId IdType="pmc">PMC8249847</ArticleId><ArticleId IdType="pubmed">34220443</ArticleId></ArticleIdList></Reference><Reference><Citation>Siniscalco D., Schultz S., Brigida A.L., Antonucci N. Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders. Pharmaceuticals. 2018;11:56. doi: 10.3390/ph11020056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph11020056</ArticleId><ArticleId IdType="pmc">PMC6027314</ArticleId><ArticleId IdType="pubmed">29867038</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Munckhof I.C.L., Kurilshikov A., ter Horst R., Riksen N.P., Joosten L.A.B., Zhernakova A., Fu J., Keating S.T., Netea M.G., de Graaf J., et al. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: A systematic review of human studies. Obes. Rev. 2018;19:1719&#x2013;1734. doi: 10.1111/obr.12750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12750</ArticleId><ArticleId IdType="pubmed">30144260</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Lee S.A., Riordan S.M., Zhang L., Zhu L. Effects of Anti-Cytokine Antibodies on Gut Barrier Function. Mediat. Inflamm. 2019;2019:7028253. doi: 10.1155/2019/7028253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7028253</ArticleId><ArticleId IdType="pmc">PMC6875247</ArticleId><ArticleId IdType="pubmed">31780866</ArticleId></ArticleIdList></Reference><Reference><Citation>Braniste V., Al-Asmakh M., Kowal C., Anuar F., Abbaspour A., T&#xf3;th M., Korecka A., Bakocevic N., Ng L.G., Kundu P. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 2014;6:263ra158. doi: 10.1126/scitranslmed.3009759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009759</ArticleId><ArticleId IdType="pmc">PMC4396848</ArticleId><ArticleId IdType="pubmed">25411471</ArticleId></ArticleIdList></Reference><Reference><Citation>Sears C.L., Geis A.L., Housseau F. Bacteroides fragilis subverts mucosal biology: From symbiont to colon carcinogenesis. J. Clin. Investig. 2014;124:4166&#x2013;4172. doi: 10.1172/JCI72334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72334</ArticleId><ArticleId IdType="pmc">PMC4191034</ArticleId><ArticleId IdType="pubmed">25105360</ArticleId></ArticleIdList></Reference><Reference><Citation>Beishuizen A., Thijs L.G. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J. Endotoxin Res. 2003;9:3&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">12691614</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichardt F., Chassaing B., Nezami B.G., Li G., Tabatabavakili S., Mwangi S., Uppal K., Liang B., Vijay-Kumar M., Jones D. Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid-and lipopolysaccharide-induced TLR4 signalling. J. Physiol. 2017;595:1831&#x2013;1846. doi: 10.1113/JP273269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP273269</ArticleId><ArticleId IdType="pmc">PMC5330876</ArticleId><ArticleId IdType="pubmed">28000223</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita &#xe5;.v., S&#xf6;derholm J.D. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol. Motil. 2010;22:718&#x2013;733. doi: 10.1111/j.1365-2982.2010.01498.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2010.01498.x</ArticleId><ArticleId IdType="pubmed">20377785</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Konstantinidou A.D. Corticotropin-releasing hormone and the blood-brain-barrier. Front. Biosci.-Landmark. 2007;12:1615&#x2013;1628. doi: 10.2741/2174.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2174</ArticleId><ArticleId IdType="pubmed">17127408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Wang N., Lu L., Ma X. Fermentation and Metabolism of Dietary Protein by Intestinal Microorganisms. Curr. Protein Pept. Sci. 2020;21:807&#x2013;811. doi: 10.2174/1389203721666200212095902.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203721666200212095902</ArticleId><ArticleId IdType="pubmed">32048966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Zhang X., Liu H., Brown M.A., Qiao S. Dietary Protein and Gut Microbiota Composition and Function. Curr. Protein Pept. Sci. 2019;20:145&#x2013;154. doi: 10.2174/1389203719666180514145437.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203719666180514145437</ArticleId><ArticleId IdType="pubmed">29756574</ArticleId></ArticleIdList></Reference><Reference><Citation>Velasquez M.T., Ramezani A., Manal A., Raj D.S. Trimethylamine N-Oxide: The Good, the Bad and the Unknown. Toxins. 2016;8:326. doi: 10.3390/toxins8110326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins8110326</ArticleId><ArticleId IdType="pmc">PMC5127123</ArticleId><ArticleId IdType="pubmed">27834801</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony S.M., Clarke G., Borre Y., Dinan T.G., Cryan J. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 2015;277:32&#x2013;48. doi: 10.1016/j.bbr.2014.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2014.07.027</ArticleId><ArticleId IdType="pubmed">25078296</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcock J., Carroll-Portillo A., Coffman C., Lin H.C. Evolution of human diet and microbiome-driven disease. Curr. Opin. Physiol. 2021;23:100455. doi: 10.1016/j.cophys.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cophys.2021.06.009</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Obesity and Overweight Fact Sheet. WHO; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Vangay P., Johnson A.J., Ward T.L., Al-Ghalith G.A., Shields-Cutler R.R., Hillmann B.M., Lucas S.K., Beura L.K., Thompson E.A., Till L.M. US immigration westernizes the human gut microbiome. Cell. 2018;175:962&#x2013;972.e910. doi: 10.1016/j.cell.2018.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.10.029</ArticleId><ArticleId IdType="pmc">PMC6498444</ArticleId><ArticleId IdType="pubmed">30388453</ArticleId></ArticleIdList></Reference><Reference><Citation>Juul F., Vaidean G., Parekh N. Ultra-processed Foods and Cardiovascular Diseases: Potential Mechanisms of Action. Adv. Nutr. 2021;12:1673&#x2013;1680. doi: 10.1093/advances/nmab049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmab049</ArticleId><ArticleId IdType="pmc">PMC8483964</ArticleId><ArticleId IdType="pubmed">33942057</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettleton J.E., Reimer R.A., Shearer J. Reshaping the gut microbiota: Impact of low calorie sweeteners and the link to insulin resistance? Physiol. Behav. 2016;164:488&#x2013;493. doi: 10.1016/j.physbeh.2016.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2016.04.029</ArticleId><ArticleId IdType="pubmed">27090230</ArticleId></ArticleIdList></Reference><Reference><Citation>Chassaing B., Van de Wiele T., De Bodt J., Marzorati M., Gewirtz A.T. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017;66:1414&#x2013;1427. doi: 10.1136/gutjnl-2016-313099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-313099</ArticleId><ArticleId IdType="pmc">PMC5940336</ArticleId><ArticleId IdType="pubmed">28325746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bana B., Cabreiro F. The Microbiome and Aging. Annu. Rev. Genet. 2019;53:239&#x2013;261. doi: 10.1146/annurev-genet-112618-043650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-112618-043650</ArticleId><ArticleId IdType="pubmed">31487470</ArticleId></ArticleIdList></Reference><Reference><Citation>Thevaranjan N., Puchta A., Schulz C., Naidoo A., Szamosi J.C., Verschoor C.P., Loukov D., Schenck L.P., Jury J., Foley K.P., et al. Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction. Cell Host Microbe. 2017;21:455&#x2013;466.e4. doi: 10.1016/j.chom.2017.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.03.002</ArticleId><ArticleId IdType="pmc">PMC5392495</ArticleId><ArticleId IdType="pubmed">28407483</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariat D., Firmesse O., Levenez F., Guimar&#x103;es V., Sokol H., Dor&#xe9; J., Corthier G., Furet J.P. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009;9:123. doi: 10.1186/1471-2180-9-123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-9-123</ArticleId><ArticleId IdType="pmc">PMC2702274</ArticleId><ArticleId IdType="pubmed">19508720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain B., Fang C., Chang J. Blood&#x2013;Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia. Front. Neurosci. 2021;15:688090. doi: 10.3389/fnins.2021.688090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.688090</ArticleId><ArticleId IdType="pmc">PMC8418300</ArticleId><ArticleId IdType="pubmed">34489623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell E., Davis A., Brass K., Dendinger M., Barner R., Gharaibeh R., Fodor A., Kavanagh K. Reduced intestinal motility, mucosal barrier function, and inflammation in aged monkeys. J. Nutr. Health Aging. 2017;21:354&#x2013;361. doi: 10.1007/s12603-016-0725-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-016-0725-y</ArticleId><ArticleId IdType="pmc">PMC6057140</ArticleId><ArticleId IdType="pubmed">28346561</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Di Benedetto S., Pawelec G. The Immune System and Its Dysregulation with Aging. In: Harris J.R., Korolchuk V.I., editors. Biochemistry and Cell Biology of Ageing: Part II Clinical Science. Springer Singapore; Singapore: 2019. pp. 21&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-3681-2_2</ArticleId><ArticleId IdType="pubmed">30888648</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maeyer R.P.H., Chambers E.S. The impact of ageing on monocytes and macrophages. Immunol. Lett. 2021;230:1&#x2013;10. doi: 10.1016/j.imlet.2020.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2020.12.003</ArticleId><ArticleId IdType="pubmed">33309673</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway J., Duggal N.A. Ageing of the gut microbiome: Potential influences on immune senescence and inflammageing. Ageing Res. Rev. 2021;68:101323. doi: 10.1016/j.arr.2021.101323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101323</ArticleId><ArticleId IdType="pubmed">33771720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan J.F., O&#x2019;Riordan K.J., Cowan C.S., Sandhu K.V., Bastiaanssen T.F., Boehme M., Codagnone M.G., Cussotto S., Fulling C., Golubeva A.V. The microbiota-gut-brain axis. Physiol. Rev. 2019;99:1877&#x2013;2013. doi: 10.1152/physrev.00018.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00018.2018</ArticleId><ArticleId IdType="pubmed">31460832</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobeiri P., Kalantari A., Teixeira A.L., Rezaei N. Shedding light on biological sex differences and microbiota&#x2013;gut&#x2013;brain axis: A comprehensive review of its roles in neuropsychiatric disorders. Biol. Sex Differ. 2022;13:12. doi: 10.1186/s13293-022-00422-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-022-00422-6</ArticleId><ArticleId IdType="pmc">PMC8949832</ArticleId><ArticleId IdType="pubmed">35337376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J., Hayes R.B. Environmental influences on the human microbiome and implications for noncommunicable disease. Annu. Rev. Public Health. 2021;42:277&#x2013;292. doi: 10.1146/annurev-publhealth-012420-105020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-012420-105020</ArticleId><ArticleId IdType="pmc">PMC8641399</ArticleId><ArticleId IdType="pubmed">33798404</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum W.E., Zechmeister-Boltenstern S., Keiblinger K.M. Does soil contribute to the human gut microbiome? Microorganisms. 2019;7:287. doi: 10.3390/microorganisms7090287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms7090287</ArticleId><ArticleId IdType="pmc">PMC6780873</ArticleId><ArticleId IdType="pubmed">31450753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprockett D., Fukami T., Relman D.A. Role of priority effects in the early-life assembly of the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 2018;15:197&#x2013;205. doi: 10.1038/nrgastro.2017.173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2017.173</ArticleId><ArticleId IdType="pmc">PMC6813786</ArticleId><ArticleId IdType="pubmed">29362469</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Peters B.A., Dominianni C., Zhang Y., Pei Z., Yang L., Ma Y., Purdue M.P., Jacobs E.J., Gapstur S.M. Cigarette smoking and the oral microbiome in a large study of American adults. ISME J. 2016;10:2435&#x2013;2446. doi: 10.1038/ismej.2016.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2016.37</ArticleId><ArticleId IdType="pmc">PMC5030690</ArticleId><ArticleId IdType="pubmed">27015003</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier L., Typas A. Systematically investigating the impact of medication on the gut microbiome. Curr. Opin. Microbiol. 2017;39:128&#x2013;135. doi: 10.1016/j.mib.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2017.11.001</ArticleId><ArticleId IdType="pubmed">29169088</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalodia R., Abu Y.F., Oppenheimer M.R., Herlihy B., Meng J., Chupikova I., Tao J., Ghosh N., Dutta R.K., Kolli U., et al. Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System. J. Neuroimmune Pharmacol. 2022;17:76&#x2013;93. doi: 10.1007/s11481-021-10046-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10046-z</ArticleId><ArticleId IdType="pmc">PMC10276355</ArticleId><ArticleId IdType="pubmed">34993905</ArticleId></ArticleIdList></Reference><Reference><Citation>Strafella C., Caputo V., Galota M.R., Zampatti S., Marella G., Mauriello S., Cascella R., Giardina E. Application of Precision Medicine in Neurodegenerative Diseases. Front. Neurol. 2018;9:701. doi: 10.3389/fneur.2018.00701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00701</ArticleId><ArticleId IdType="pmc">PMC6115491</ArticleId><ArticleId IdType="pubmed">30190701</ArticleId></ArticleIdList></Reference><Reference><Citation>Vich Vila A., Collij V., Sanna S., Sinha T., Imhann F., Bourgonje A.R., Mujagic Z., Jonkers D.M.A.E., Masclee A.A.M., Fu J., et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat. Commun. 2020;11:362. doi: 10.1038/s41467-019-14177-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14177-z</ArticleId><ArticleId IdType="pmc">PMC6969170</ArticleId><ArticleId IdType="pubmed">31953381</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-Q., Gong J.-Y., Xing K., Liu M.-Z., Ren H., Luo J.-Q. Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment. Front. Med. 2022;8:742394. doi: 10.3389/fmed.2021.742394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.742394</ArticleId><ArticleId IdType="pmc">PMC8808336</ArticleId><ArticleId IdType="pubmed">35127738</ArticleId></ArticleIdList></Reference><Reference><Citation>Weersma R.K., Zhernakova A., Fu J. Interaction between drugs and the gut microbiome. Gut. 2020;69:1510&#x2013;1519. doi: 10.1136/gutjnl-2019-320204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2019-320204</ArticleId><ArticleId IdType="pmc">PMC7398478</ArticleId><ArticleId IdType="pubmed">32409589</ArticleId></ArticleIdList></Reference><Reference><Citation>Iizumi T., Battaglia T., Ruiz V., Perez G.I.P. Gut microbiome and antibiotics. Arch. Med. Res. 2017;48:727&#x2013;734. doi: 10.1016/j.arcmed.2017.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2017.11.004</ArticleId><ArticleId IdType="pubmed">29221800</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidis T., Tsigalou C., Karvelas A., Stavropoulou E., Voidarou C., Bezirtzoglou E. Effects of antibiotics upon the gut microbiome: A review of the literature. Biomedicines. 2020;8:502. doi: 10.3390/biomedicines8110502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8110502</ArticleId><ArticleId IdType="pmc">PMC7696078</ArticleId><ArticleId IdType="pubmed">33207631</ArticleId></ArticleIdList></Reference><Reference><Citation>Langdon A., Crook N., Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 2016;8:39. doi: 10.1186/s13073-016-0294-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-016-0294-z</ArticleId><ArticleId IdType="pmc">PMC4831151</ArticleId><ArticleId IdType="pubmed">27074706</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhu X., Li R., Zhang J., Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: Insights from a single-centred retrospective study. BMJ Open. 2020;10:e040473. doi: 10.1136/bmjopen-2020-040473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040473</ArticleId><ArticleId IdType="pmc">PMC7692833</ArticleId><ArticleId IdType="pubmed">33243802</ArticleId></ArticleIdList></Reference><Reference><Citation>Imhann F., Bonder M.J., Vich Vila A., Fu J., Mujagic Z., Vork L., Tigchelaar E.F., Jankipersadsing S.A., Cenit M.C., Harmsen H.J., et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65:740&#x2013;748. doi: 10.1136/gutjnl-2015-310376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2015-310376</ArticleId><ArticleId IdType="pmc">PMC4853569</ArticleId><ArticleId IdType="pubmed">26657899</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno G., Zaccari P., Rocco G., Scalese G., Panetta C., Porowska B., Pontone S., Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J. Gastroenterol. 2019;25:2706&#x2013;2719. doi: 10.3748/wjg.v25.i22.2706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v25.i22.2706</ArticleId><ArticleId IdType="pmc">PMC6580352</ArticleId><ArticleId IdType="pubmed">31235994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;stedt P., Enander J., Isung J. Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis. Front. Psychiatry. 2021;12:682868. doi: 10.3389/fpsyt.2021.682868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.682868</ArticleId><ArticleId IdType="pmc">PMC8187765</ArticleId><ArticleId IdType="pubmed">34122195</ArticleId></ArticleIdList></Reference><Reference><Citation>Letchumanan V., Thye A.Y.-K., Tan L.T.-H., Law J.W.-F., Johnson D., Ser H.-L., Bhuvanendran S., Thurairajasingam S., Lee L.-H. IDDF2021-ABS-0164 Gut feelings in depression: Microbiota dysbiosis in response to antidepressants. Gut. 2021;70:A49&#x2013;A50. doi: 10.1136/gutjnl-2021-IDDF.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-IDDF.47</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan A.P., Crowley J.J., Nonneman R.J., Quackenbush C.R., Miller C.N., Ryan A.K., Bogue M.A., Paredes S.H., Yourstone S., Carroll I.M. The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS ONE. 2014;9:e115225. doi: 10.1371/journal.pone.0115225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115225</ArticleId><ArticleId IdType="pmc">PMC4266663</ArticleId><ArticleId IdType="pubmed">25506936</ArticleId></ArticleIdList></Reference><Reference><Citation>Melis M., Vascellari S., Santoru M.L., Oppo V., Fabbri M., Sarchioto M., Murgia D., Zibetti M., Lopiano L., Serra A., et al. Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel. Eur. J. Neurol. 2021;28:1198&#x2013;1209. doi: 10.1111/ene.14644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14644</ArticleId><ArticleId IdType="pubmed">33185912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubomski M., Tan A.H., Lim S.-Y., Holmes A.J., Davis R.L., Sue C.M. Parkinson&#x2019;s disease and the gastrointestinal microbiome. J. Neurol. 2020;267:2507&#x2013;2523. doi: 10.1007/s00415-019-09320-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09320-1</ArticleId><ArticleId IdType="pubmed">31041582</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios N., Hannoun A., Flahive J., Ward D., Goostrey K., Deb A., Smith K.M. Effect of Levodopa Initiation on the Gut Microbiota in Parkinson&#x2019;s Disease. Front. Neurol. 2021;12:574529. doi: 10.3389/fneur.2021.574529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.574529</ArticleId><ArticleId IdType="pmc">PMC7970035</ArticleId><ArticleId IdType="pubmed">33746867</ArticleId></ArticleIdList></Reference><Reference><Citation>Maini Rekdal V., Bess E.N., Bisanz J.E., Turnbaugh P.J., Balskus E.P. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019;364:eaau6323. doi: 10.1126/science.aau6323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aau6323</ArticleId><ArticleId IdType="pmc">PMC7745125</ArticleId><ArticleId IdType="pubmed">31196984</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichella M., Severgnini M., Cilia R., Cassani E., Bolliri C., Caronni S., Ferri V., Cancello R., Ceccarani C., Faierman S. Unraveling gut microbiota in Parkinson&#x2019;s disease and atypical parkinsonism. Mov. Disord. 2019;34:396&#x2013;405. doi: 10.1002/mds.27581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27581</ArticleId><ArticleId IdType="pubmed">30576008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill-Burns E.M., Debelius J.W., Morton J.T., Wissemann W.T., Lewis M.R., Wallen Z.D., Peddada S.D., Factor S.A., Molho E., Zabetian C.P. Parkinson&#x2019;s disease and Parkinson&#x2019;s disease medications have distinct signatures of the gut microbiome. Mov. Disord. 2017;32:739&#x2013;749. doi: 10.1002/mds.26942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26942</ArticleId><ArticleId IdType="pmc">PMC5469442</ArticleId><ArticleId IdType="pubmed">28195358</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheperjans F., Aho V., Pereira P.A., Koskinen K., Paulin L., Pekkonen E., Haapaniemi E., Kaakkola S., Eerola-Rautio J., Pohja M. Gut microbiota are related to Parkinson&#x2019;s disease and clinical phenotype. Mov. Disord. 2015;30:350&#x2013;358. doi: 10.1002/mds.26069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26069</ArticleId><ArticleId IdType="pubmed">25476529</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen V.T.T., Sallbach J., Dos Santos Guilherme M., Endres K. Influence of Acetylcholine Esterase Inhibitors and Memantine, Clinically Approved for Alzheimer&#x2019;s Dementia Treatment, on Intestinal Properties of the Mouse. Int. J. Mol. Sci. 2021;22:1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864027</ArticleId><ArticleId IdType="pubmed">33498392</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer C.M., Noble S. Rivastigmine. A review of its use in Alzheimer&#x2019;s disease. Drugs Aging. 1998;13:391&#x2013;411. doi: 10.2165/00002512-199813050-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002512-199813050-00005</ArticleId><ArticleId IdType="pubmed">9829166</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliuca R., Papa M.V., Ilaria P.M., Papa V.F., Varricchio G. Atypical Presentation of Acetylcholinesterase Inhibitor-Induced Diarrhea in Older Adults with Cognitive Decline: An Aspect not to be Underestimated. Ann. Geriatr. Med. Res. 2023;27:83&#x2013;86. doi: 10.4235/agmr.22.0116.</Citation><ArticleIdList><ArticleId IdType="doi">10.4235/agmr.22.0116</ArticleId><ArticleId IdType="pmc">PMC10073974</ArticleId><ArticleId IdType="pubmed">36726051</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahr S.M., Weidemann B.J., Castro A.N., Walsh J.W., deLeon O., Burnett C.M.L., Pearson N.A., Murry D.J., Grobe J.L., Kirby J.R. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. eBioMedicine. 2015;2:1725&#x2013;1734. doi: 10.1016/j.ebiom.2015.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.10.018</ArticleId><ArticleId IdType="pmc">PMC4740326</ArticleId><ArticleId IdType="pubmed">26870798</ArticleId></ArticleIdList></Reference><Reference><Citation>Cussotto S., Clarke G., Dinan T.G., Cryan J.F. Psychotropics and the Microbiome: A Chamber of Secrets&#x2026;. Psychopharmacology. 2019;236:1411&#x2013;1432. doi: 10.1007/s00213-019-5185-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-019-5185-8</ArticleId><ArticleId IdType="pmc">PMC6598948</ArticleId><ArticleId IdType="pubmed">30806744</ArticleId></ArticleIdList></Reference><Reference><Citation>Boertien J.M., Pereira P.A., Aho V.T., Scheperjans F. Increasing comparability and utility of gut microbiome studies in Parkinson&#x2019;s disease: A systematic review. J. Park. Dis. 2019;9:S297&#x2013;S312. doi: 10.3233/JPD-191711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-191711</ArticleId><ArticleId IdType="pmc">PMC6839453</ArticleId><ArticleId IdType="pubmed">31498131</ArticleId></ArticleIdList></Reference><Reference><Citation>Haikal C., Chen Q.-Q., Li J.-Y. Microbiome changes: An indicator of Parkinson&#x2019;s disease? Transl. Neurodegener. 2019;8:38. doi: 10.1186/s40035-019-0175-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-019-0175-7</ArticleId><ArticleId IdType="pmc">PMC6929290</ArticleId><ArticleId IdType="pubmed">31890161</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinzel S., Aho V.T., Suenkel U., von Thaler A.K., Schulte C., Deuschle C., Paulin L., Hantunen S., Brockmann K., Eschweiler G.W. Gut microbiome signatures of risk and prodromal markers of Parkinson disease. Ann. Neurol. 2020;88:320&#x2013;331. doi: 10.1002/ana.25788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25788</ArticleId><ArticleId IdType="pubmed">32441370</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiwaki H., Ito M., Ishida T., Hamaguchi T., Maeda T., Kashihara K., Tsuboi Y., Ueyama J., Shimamura T., Mori H., et al. Meta-Analysis of Gut Dysbiosis in Parkinson&#x2019;s Disease. Mov. Disord. 2020;35:1626&#x2013;1635. doi: 10.1002/mds.28119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28119</ArticleId><ArticleId IdType="pubmed">32557853</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullich C., Keshavarzian A., Garssen J., Kraneveld A., Perez-Pardo P. Gut Vibes in Parkinson&#x2019;s Disease: The Microbiota-Gut-Brain Axis. Mov. Disord. Clin. Pract. 2019;6:639&#x2013;651. doi: 10.1002/mdc3.12840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.12840</ArticleId><ArticleId IdType="pmc">PMC6856467</ArticleId><ArticleId IdType="pubmed">31745471</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson T.R., Debelius J.W., Thron T., Janssen S., Shastri G.G., Ilhan Z.E., Challis C., Schretter C.E., Rocha S., Gradinaru V., et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson&#x2019;s Disease. Cell. 2016;167:1469&#x2013;1480.e12. doi: 10.1016/j.cell.2016.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5718049</ArticleId><ArticleId IdType="pubmed">27912057</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabrucker S., Marizzoni M., Silajd&#x17e;i&#x107; E., Lopizzo N., Mombelli E., Nicolas S., Dohm-Hansen S., Scassellati C., Moretti D.V., Rosa M., et al. Faecal microbiota transplantation from Alzheimer&#x2019;s participants induces impairments in neurogenesis and cognitive behaviours in rats. bioRxiv. 2022 doi: 10.1101/2022.11.04.515189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.04.515189</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavarzian A., Green S.J., Engen P.A., Voigt R.M., Naqib A., Forsyth C.B., Mutlu E., Shannon K.M. Colonic bacterial composition in Parkinson&#x2019;s disease. Mov. Disord. 2015;30:1351&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pubmed">26179554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedarf J.R., Hildebrand F., Coelho L.P., Sunagawa S., Bahram M., Goeser F., Bork P., W&#xfc;llner U. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na&#xef;ve Parkinson&#x2019;s disease patients. Genome Med. 2017;9:39. doi: 10.1186/s13073-017-0428-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-017-0428-y</ArticleId><ArticleId IdType="pmc">PMC5408370</ArticleId><ArticleId IdType="pubmed">28449715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa S., Goto S., Tsuji H., Okuno T., Asahara T., Nomoto K., Shibata A., Fujisawa Y., Minato T., Okamoto A. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson&#x2019;s disease. PLoS ONE. 2015;10:e0142164. doi: 10.1371/journal.pone.0142164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142164</ArticleId><ArticleId IdType="pmc">PMC4634857</ArticleId><ArticleId IdType="pubmed">26539989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopfner F., K&#xfc;nstner A., M&#xfc;ller S.H., K&#xfc;nzel S., Zeuner K.E., Margraf N.G., Deuschl G., Baines J.F., Kuhlenb&#xe4;umer G. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 2017;1667:41&#x2013;45. doi: 10.1016/j.brainres.2017.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2017.04.019</ArticleId><ArticleId IdType="pubmed">28506555</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Cui L., Yang Y., Miao J., Zhao X., Zhang J., Cui G., Zhang Y. Gut microbiota differs between Parkinson&#x2019;s disease patients and healthy controls in northeast China. Front. Mol. Neurosci. 2019;12:171. doi: 10.3389/fnmol.2019.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00171</ArticleId><ArticleId IdType="pmc">PMC6637281</ArticleId><ArticleId IdType="pubmed">31354427</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Wang P., Chen Z., Sui X., Xie X., Zhang J. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson&#x2019;s disease. Neurosci. Lett. 2019;707:134297. doi: 10.1016/j.neulet.2019.134297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134297</ArticleId><ArticleId IdType="pubmed">31200089</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Wu X., Hu X., Wang T., Liang S., Duan Y., Jin F., Qin B. Structural changes of gut microbiota in Parkinson&#x2019;s disease and its correlation with clinical features. Sci. China Life Sci. 2017;60:1223&#x2013;1233. doi: 10.1007/s11427-016-9001-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-016-9001-4</ArticleId><ArticleId IdType="pubmed">28536926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin A., Zheng W., He Y., Tang W., Wei X., He R., Huang W., Su Y., Huang Y., Zhou H. Gut microbiota in patients with Parkinson&#x2019;s disease in southern China. Park. Relat. Disord. 2018;53:82&#x2013;88. doi: 10.1016/j.parkreldis.2018.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2018.05.007</ArticleId><ArticleId IdType="pubmed">29776865</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y., Yang X., Xu S., Wu C., Song Y., Qin N., Chen S.-D., Xiao Q. Alteration of the fecal microbiota in Chinese patients with Parkinson&#x2019;s disease. Brain Behav. Immun. 2018;70:194&#x2013;202. doi: 10.1016/j.bbi.2018.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.02.016</ArticleId><ArticleId IdType="pubmed">29501802</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger M.M., Spiegel J., Dillmann K.-U., Grundmann D., Philippeit H., B&#xfc;rmann J., Fa&#xdf;bender K., Schwiertz A., Sch&#xe4;fer K.-H. Short chain fatty acids and gut microbiota differ between patients with Parkinson&#x2019;s disease and age-matched controls. Park. Relat. Disord. 2016;32:66&#x2013;72. doi: 10.1016/j.parkreldis.2016.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2016.08.019</ArticleId><ArticleId IdType="pubmed">27591074</ArticleId></ArticleIdList></Reference><Reference><Citation>Vascellari S., Palmas V., Melis M., Pisanu S., Cusano R., Uva P., Perra D., Madau V., Sarchioto M., Oppo V. Gut microbiota and metabolome alterations associated with Parkinson&#x2019;s disease. Msystems. 2020;5:e00561-20. doi: 10.1128/mSystems.00561-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.00561-20</ArticleId><ArticleId IdType="pmc">PMC7498685</ArticleId><ArticleId IdType="pubmed">32934117</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini F., Hertel J., Sandt E., Thinnes C.C., Neuberger-Castillo L., Pavelka L., Betsou F., Kr&#xfc;ger R., Thiele I. Parkinson&#x2019;s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol. 2020;18:62. doi: 10.1186/s12915-020-00775-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-00775-7</ArticleId><ArticleId IdType="pmc">PMC7285525</ArticleId><ArticleId IdType="pubmed">32517799</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirstea M.S., Yu A.C., Golz E., Sundvick K., Kliger D., Radisavljevic N., Foulger L.H., Mackenzie M., Huan T., Finlay B.B. Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson&#x2019;s Disease. Mov. Disord. 2020;35:1208&#x2013;1217. doi: 10.1002/mds.28052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28052</ArticleId><ArticleId IdType="pubmed">32357258</ArticleId></ArticleIdList></Reference><Reference><Citation>Heintz-Buschart A., Pandey U., Wicke T., Sixel-D&#xf6;ring F., Janzen A., Sittig-Wiegand E., Trenkwalder C., Oertel W.H., Mollenhauer B., Wilmes P. The nasal and gut microbiome in Parkinson&#x2019;s disease and idiopathic rapid eye movement sleep behavior disorder. Mov. Disord. 2018;33:88&#x2013;98. doi: 10.1002/mds.27105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27105</ArticleId><ArticleId IdType="pmc">PMC5811909</ArticleId><ArticleId IdType="pubmed">28843021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., Li J., Liu F., Lyu N., Wang K., Wang L., Liang S., Tao H., Zhu B., Alkasir R. Analysis of the Gut Microflora in Patients With Parkinson&#x2019;s Disease. Front. Neurosci. 2019;13:1184. doi: 10.3389/fnins.2019.01184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01184</ArticleId><ArticleId IdType="pmc">PMC6883725</ArticleId><ArticleId IdType="pubmed">31824239</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallen Z.D., Appah M., Dean M.N., Sesler C.L., Factor S.A., Molho E., Zabetian C.P., Standaert D.G., Payami H. Characterizing dysbiosis of gut microbiome in PD: Evidence for overabundance of opportunistic pathogens. npj Park. Dis. 2020;6:11. doi: 10.1038/s41531-020-0112-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-0112-6</ArticleId><ArticleId IdType="pmc">PMC7293233</ArticleId><ArticleId IdType="pubmed">32566740</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsyth C.B., Shannon K.M., Kordower J.H., Voigt R.M., Shaikh M., Jaglin J.A., Estes J.D., Dodiya H.B., Keshavarzian A. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson&#x2019;s disease. PLoS ONE. 2011;6:e28032. doi: 10.1371/journal.pone.0028032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0028032</ArticleId><ArticleId IdType="pmc">PMC3228722</ArticleId><ArticleId IdType="pubmed">22145021</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo A.R.L., Monroy G.R., Salazar F.E., Lee J.-Y., Jain S., Yadav H., Borlongan C.V. Gut&#x2013;brain axis as a pathological and therapeutic target for neurodegenerative disorders. Int. J. Mol. Sci. 2022;23:1184. doi: 10.3390/ijms23031184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031184</ArticleId><ArticleId IdType="pmc">PMC8834995</ArticleId><ArticleId IdType="pubmed">35163103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S.R., Banerjee S. Gut microbiota in neurodegenerative disorders. J. Neuroimmunol. 2019;328:98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">30658292</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald E., Murphy S., Martinson H.A. Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson&#x2019;s Disease. Front. Neurosci. 2019;13:369. doi: 10.3389/fnins.2019.00369.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00369</ArticleId><ArticleId IdType="pmc">PMC6491838</ArticleId><ArticleId IdType="pubmed">31068777</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedland R.P., Chapman M.R. The role of microbial amyloid in neurodegeneration. PLoS Pathog. 2017;13:e1006654. doi: 10.1371/journal.ppat.1006654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006654</ArticleId><ArticleId IdType="pmc">PMC5739464</ArticleId><ArticleId IdType="pubmed">29267402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Kwon S.-H., Kam T.-I., Panicker N., Karuppagounder S.S., Lee S., Lee J.H., Kim W.R., Kook M., Foss C.A., et al. Transneuronal Propagation of Pathologic &#x3b1;-Synuclein from the Gut to the Brain Models Parkinson&#x2019;s Disease. Neuron. 2019;103:627&#x2013;641.e7. doi: 10.1016/j.neuron.2019.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.035</ArticleId><ArticleId IdType="pmc">PMC6706297</ArticleId><ArticleId IdType="pubmed">31255487</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura N., Yagi H., Uemura M.T., Hatanaka Y., Yamakado H., Takahashi R. Inoculation of &#x3b1;-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol. Neurodegener. 2018;13:21. doi: 10.1186/s13024-018-0257-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0257-5</ArticleId><ArticleId IdType="pmc">PMC5948849</ArticleId><ArticleId IdType="pubmed">29751824</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Fang F., Pedersen N.L., Tillander A., Ludvigsson J.F., Ekbom A., Svenningsson P., Chen H., Wirdefeldt K. Vagotomy and Parkinson disease: A Swedish register&#x2013;based matched-cohort study. Neurology. 2017;88:1996&#x2013;2002. doi: 10.1212/WNL.0000000000003961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003961</ArticleId><ArticleId IdType="pmc">PMC5440238</ArticleId><ArticleId IdType="pubmed">28446653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouli A., Horne C.B., Williams-Gray C.H. Toll-like receptors and their therapeutic potential in Parkinson&#x2019;s disease and &#x3b1;-synucleinopathies. Brain Behav. Immun. 2019;81:41&#x2013;51. doi: 10.1016/j.bbi.2019.06.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.06.042</ArticleId><ArticleId IdType="pubmed">31271873</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Berge N., Ferreira N., Mikkelsen T.W., Alstrup A.K.O., Tamg&#xfc;ney G., Karlsson P., Terkelsen A.J., Nyengaard J.R., Jensen P.H., Borghammer P. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain. 2021;144:1853&#x2013;1868. doi: 10.1093/brain/awab061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab061</ArticleId><ArticleId IdType="pmc">PMC8320301</ArticleId><ArticleId IdType="pubmed">33880502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Blanco L.P., Smith D.R., Chapman M.R. Bacterial amyloids. Methods Mol. Biol. 2012;849:303&#x2013;320. doi: 10.1007/978-1-61779-551-0_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-551-0_21</ArticleId><ArticleId IdType="pmc">PMC5324733</ArticleId><ArticleId IdType="pubmed">22528099</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesnick T.G., Papapetropoulos S., Mash D.C., Ffrench-Mullen J., Shehadeh L., De Andrade M., Henley J.R., Rocca W.A., Ahlskog J.E., Maraganore D.M. A genomic pathway approach to a complex disease: Axon guidance and Parkinson disease. PLoS Genet. 2007;3:e98. doi: 10.1371/journal.pgen.0030098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030098</ArticleId><ArticleId IdType="pmc">PMC1904362</ArticleId><ArticleId IdType="pubmed">17571925</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls M.A., Blauwendraat C., Vallerga C.L., Heilbron K., Bandres-Ciga S., Chang D., Tan M., Kia D.A., Noyce A.J., Xue A. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: A meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang S.Y.-Y., Ho P.W.-L., Liu H.-F., Leung C.-T., Li L., Chang E.E.S., Ramsden D.B., Ho S.-L. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson&#x2019;s disease. Transl. Neurodegener. 2019;8:23. doi: 10.1186/s40035-019-0165-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-019-0165-9</ArticleId><ArticleId IdType="pmc">PMC6696688</ArticleId><ArticleId IdType="pubmed">31428316</ArticleId></ArticleIdList></Reference><Reference><Citation>Marras C., Canning C.G., Goldman S.M. Environment, lifestyle, and Parkinson&#x2019;s disease: Implications for prevention in the next decade. Mov. Disord. 2019;34:801&#x2013;811. doi: 10.1002/mds.27720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27720</ArticleId><ArticleId IdType="pubmed">31091353</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H.C., Ulane C.M., Burke R.E. Clinical progression in Parkinson disease and the neurobiology of axons. Ann. Neurol. 2010;67:715&#x2013;725. doi: 10.1002/ana.21995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21995</ArticleId><ArticleId IdType="pmc">PMC2918373</ArticleId><ArticleId IdType="pubmed">20517933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye J., Gage H., Kimber A., Storey L., Trend P. Excess burden of constipation in Parkinson&#x2019;s disease: A pilot study. Mov. Disord. Off. J. Mov. Disord. Soc. 2006;21:1270&#x2013;1273. doi: 10.1002/mds.20942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.20942</ArticleId><ArticleId IdType="pubmed">16700046</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudsen K., Krogh K., &#xd8;stergaard K., Borghammer P. Constipation in Parkinson&#x2019;s disease: Subjective symptoms, objective markers, and new perspectives. Mov. Disord. 2017;32:94&#x2013;105. doi: 10.1002/mds.26866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26866</ArticleId><ArticleId IdType="pubmed">27873359</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg D., Postuma R.B., Adler C.H., Bloem B.R., Chan P., Dubois B., Gasser T., Goetz C.G., Halliday G., Joseph L. MDS research criteria for prodromal Parkinson&#x2019;s disease. Mov. Disord. 2015;30:1600&#x2013;1611. doi: 10.1002/mds.26431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26431</ArticleId><ArticleId IdType="pubmed">26474317</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon K.M., Keshavarzian A., Dodiya H.B., Jakate S., Kordower J.H. Is alpha-synuclein in the colon a biomarker for premotor Parkinson&#x2019;s disease? Evidence from 3 cases. Mov. Disord. 2012;27:716&#x2013;719. doi: 10.1002/mds.25020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25020</ArticleId><ArticleId IdType="pubmed">22550057</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., R&#xfc;b U., Gai W., Del Tredici K. Idiopathic Parkinson&#x2019;s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 2003;110:517&#x2013;536. doi: 10.1007/s00702-002-0808-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-002-0808-2</ArticleId><ArticleId IdType="pubmed">12721813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes C.H., Del Tredici K., Braak H. Parkinson&#x2019;s disease: A dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 2007;33:599&#x2013;614. doi: 10.1111/j.1365-2990.2007.00874.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2007.00874.x</ArticleId><ArticleId IdType="pmc">PMC7194308</ArticleId><ArticleId IdType="pubmed">17961138</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbut D., Stolzenberg E., Zasloff M. Gastrointestinal Immunity and Alpha-Synuclein. J. Park. Dis. 2019;9:S313&#x2013;S322. doi: 10.3233/JPD-191702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-191702</ArticleId><ArticleId IdType="pmc">PMC6839499</ArticleId><ArticleId IdType="pubmed">31594249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.G., Stribinskis V., Rane M.J., Demuth D.R., Gozal E., Roberts A.M., Jagadapillai R., Liu R., Choe K., Shivakumar B. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and Caenorhabditis elegans. Sci. Rep. 2016;6:34477. doi: 10.1038/srep34477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34477</ArticleId><ArticleId IdType="pmc">PMC5052651</ArticleId><ArticleId IdType="pubmed">27708338</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitetta L., Chen J., Clarke S. The vermiform appendix: An immunological organ sustaining a microbiome inoculum. Clin. Sci. 2019;133:1&#x2013;8. doi: 10.1042/CS20180956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180956</ArticleId><ArticleId IdType="pubmed">30606811</ArticleId></ArticleIdList></Reference><Reference><Citation>Killinger B., Labrie V. The Appendix in Parkinson&#x2019;s Disease: From Vestigial Remnant to Vital Organ? J. Park. Dis. 2019;9:S345&#x2013;S358. doi: 10.3233/JPD-191703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-191703</ArticleId><ArticleId IdType="pmc">PMC6839473</ArticleId><ArticleId IdType="pubmed">31609697</ArticleId></ArticleIdList></Reference><Reference><Citation>Villumsen M., Aznar S., Pakkenberg B., Jess T., Brudek T. Inflammatory bowel disease increases the risk of Parkinson&#x2019;s disease: A Danish nationwide cohort study 1977&#x2013;2014. Gut. 2019;68:18&#x2013;24. doi: 10.1136/gutjnl-2017-315666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2017-315666</ArticleId><ArticleId IdType="pubmed">29785965</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu P., Gao M., Yung K.K.L. Association of intestinal disorders with Parkinson&#x2019;s disease and Alzheimer&#x2019;s disease: A systematic review and meta-analysis. ACS Chem. Neurosci. 2019;11:395&#x2013;405. doi: 10.1021/acschemneuro.9b00607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00607</ArticleId><ArticleId IdType="pubmed">31876406</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Sj&#xf6;lander A., Pedersen N.L., Ludvigsson J.F., Chen H., Fang F., Wirdefeldt K. Irritable bowel syndrome and Parkinson&#x2019;s disease risk: Register-based studies. npj Park. Dis. 2021;7:5. doi: 10.1038/s41531-020-00145-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00145-8</ArticleId><ArticleId IdType="pmc">PMC7785733</ArticleId><ArticleId IdType="pubmed">33402695</ArticleId></ArticleIdList></Reference><Reference><Citation>Tern&#xe1;k G., Kuti D., Kov&#xe1;cs K.J. Dysbiosis in Parkinson&#x2019;s disease might be triggered by certain antibiotics. Med. Hypotheses. 2020;137:109564. doi: 10.1016/j.mehy.2020.109564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109564</ArticleId><ArticleId IdType="pubmed">31954994</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertsalmi T.H., Pekkonen E., Scheperjans F. Antibiotic exposure and risk of Parkinson&#x2019;s disease in Finland: A nationwide case-control study. Mov. Disord. 2020;35:431&#x2013;442. doi: 10.1002/mds.27924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27924</ArticleId><ArticleId IdType="pubmed">31737957</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho V.T.E., Houser M.C., Pereira P.A.B., Chang J., Rudi K., Paulin L., Hertzberg V., Auvinen P., Tansey M.G., Scheperjans F. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson&#x2019;s disease. Mol. Neurodegener. 2021;16:6. doi: 10.1186/s13024-021-00427-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00427-6</ArticleId><ArticleId IdType="pmc">PMC7869249</ArticleId><ArticleId IdType="pubmed">33557896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.-H., Chen C.-C., Chiang H.-L., Liou J.-M., Chang C.-M., Lu T.-P., Chuang E.Y., Tai Y.-C., Cheng C., Lin H.-Y. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson&#x2019;s disease. J. Neuroinflammation. 2019;16:129. doi: 10.1186/s12974-019-1528-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1528-y</ArticleId><ArticleId IdType="pmc">PMC6598278</ArticleId><ArticleId IdType="pubmed">31248424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallen Z.D., Demirkan A., Twa G., Cohen G., Dean M.N., Standaert D.G., Sampson T.R., Payami H. Metagenomics of Parkinson&#x2019;s disease implicates the gut microbiome in multiple disease mechanisms. Nat. Commun. 2022;13:6958. doi: 10.1038/s41467-022-34667-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34667-x</ArticleId><ArticleId IdType="pmc">PMC9663292</ArticleId><ArticleId IdType="pubmed">36376318</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh T.S., Chong C.W., Lim S.-Y., Bowman J., Cirstea M., Lin C.-H., Chen C.-C., Appel-Cresswell S., Finlay B.B., Tan A.H. Gut microbiome in Parkinson&#x2019;s disease: New insights from meta-analysis. Park. Relat. Disord. 2022;94:1&#x2013;9. doi: 10.1016/j.parkreldis.2021.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2021.11.017</ArticleId><ArticleId IdType="pubmed">34844021</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano S., Savva G.M., Bedarf J.R., Charles I.G., Hildebrand F., Narbad A. Meta-analysis of the Parkinson&#x2019;s disease gut microbiome suggests alterations linked to intestinal inflammation. npj Park. Dis. 2021;7:27. doi: 10.1038/s41531-021-00156-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-021-00156-z</ArticleId><ArticleId IdType="pmc">PMC7946946</ArticleId><ArticleId IdType="pubmed">33692356</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulos C., Yaghi N., El Hayeck R., Heraoui G.N., Fakhoury-Sayegh N. Nutritional risk factors, microbiota and Parkinson&#x2019;s disease: What is the current evidence? Nutrients. 2019;11:1896. doi: 10.3390/nu11081896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11081896</ArticleId><ArticleId IdType="pmc">PMC6722832</ArticleId><ArticleId IdType="pubmed">31416163</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight E., Geetha T., Burnett D., Babu J.R. The Role of Diet and Dietary Patterns in Parkinson&#x2019;s Disease. Nutrients. 2022;14:4472. doi: 10.3390/nu14214472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14214472</ArticleId><ArticleId IdType="pmc">PMC9654624</ArticleId><ArticleId IdType="pubmed">36364733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C.-Y., He F.-F., Su H., Zhang C., Meng X.-F. Association between chronic kidney disease and Alzheimer&#x2019;s disease: An update. Metab. Brain Dis. 2020;35:883&#x2013;894. doi: 10.1007/s11011-020-00561-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-020-00561-y</ArticleId><ArticleId IdType="pubmed">32246323</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian J., Liebert A., Bicknell B., Chen X.-M., Huang C., Pollock C.A. Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients. 2022;14:2528. doi: 10.3390/nu14122528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14122528</ArticleId><ArticleId IdType="pmc">PMC9228952</ArticleId><ArticleId IdType="pubmed">35745257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill J.M., Clement C., Pogue A.I., Bhattacharjee S., Zhao Y., Lukiw W.J. Pathogenic microbes, the microbiome, and Alzheimer&#x2019;s disease (AD) Front. Aging Neurosci. 2014;6:127. doi: 10.3389/fnagi.2014.00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00127</ArticleId><ArticleId IdType="pmc">PMC4058571</ArticleId><ArticleId IdType="pubmed">24982633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersant H., Grossberg G. The Ketogenic Diet and Alzheimer&#x2019;s Disease. J. Nutr. Health Aging. 2022;26:606&#x2013;614. doi: 10.1007/s12603-022-1807-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-022-1807-7</ArticleId><ArticleId IdType="pubmed">35718870</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant W.B. Using multicountry ecological and observational studies to determine dietary risk factors for Alzheimer&#x2019;s disease. J. Am. Coll. Nutr. 2016;35:476&#x2013;489. doi: 10.1080/07315724.2016.1161566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2016.1161566</ArticleId><ArticleId IdType="pubmed">27454859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra S., Sisodia S.S., Vassar R.J. The gut microbiome in Alzheimer&#x2019;s disease: What we know and what remains to be explored. Mol. Neurodegener. 2023;18:9. doi: 10.1186/s13024-023-00595-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-023-00595-7</ArticleId><ArticleId IdType="pmc">PMC9889249</ArticleId><ArticleId IdType="pubmed">36721148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M., Park S.J., Choi S., Chang J., Kim S.M., Jeong S., Park Y.J., Lee G., Son J.S., Ahn J.C., et al. Association between antibiotics and dementia risk: A retrospective cohort study. Front. Pharmacol. 2022;13:888333. doi: 10.3389/fphar.2022.888333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.888333</ArticleId><ArticleId IdType="pmc">PMC9548656</ArticleId><ArticleId IdType="pubmed">36225572</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt N.M., Kerby R.L., Dill-McFarland K.A., Harding S.J., Merluzzi A.P., Johnson S.C., Carlsson C.M., Asthana S., Zetterberg H., Blennow K. Gut microbiome alterations in Alzheimer&#x2019;s disease. Sci. Rep. 2017;7:13537. doi: 10.1038/s41598-017-13601-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13601-y</ArticleId><ArticleId IdType="pmc">PMC5648830</ArticleId><ArticleId IdType="pubmed">29051531</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Wu L., Peng G., Han Y., Tang R., Ge J., Zhang L., Jia L., Yue S., Zhou K. Altered microbiomes distinguish Alzheimer&#x2019;s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav. Immun. 2019;80:633&#x2013;643. doi: 10.1016/j.bbi.2019.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.05.008</ArticleId><ArticleId IdType="pubmed">31063846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Z.-Q., Shen L.-L., Li W.-W., Fu X., Zeng F., Gui L., L&#xfc; Y., Cai M., Zhu C., Tan Y.-L. Gut microbiota is altered in patients with Alzheimer&#x2019;s disease. J. Alzheimer&#x2019;s Dis. 2018;63:1337&#x2013;1346. doi: 10.3233/JAD-180176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180176</ArticleId><ArticleId IdType="pubmed">29758946</ArticleId></ArticleIdList></Reference><Reference><Citation>Asti A., Gioglio L. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J. Alzheimer&#x2019;s Dis. 2014;39:169&#x2013;179. doi: 10.3233/JAD-131394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-131394</ArticleId><ArticleId IdType="pubmed">24150108</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida M.N., Silvernale C., Kuo B., Staller K. Bowel symptoms predate the diagnosis among many patients with multiple sclerosis: A 14-year cohort study. Neurogastroenterol. Motil. 2019;31:e13592. doi: 10.1111/nmo.13592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13592</ArticleId><ArticleId IdType="pubmed">30957307</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna L., Zeydan B., Kantarci O.H., Camilleri M. Gastrointestinal motility disorders in patients with multiple sclerosis: A single-center study. Neurogastroenterol. Motil. 2022;34:e14326. doi: 10.1111/nmo.14326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14326</ArticleId><ArticleId IdType="pmc">PMC9338921</ArticleId><ArticleId IdType="pubmed">35112759</ArticleId></ArticleIdList></Reference><Reference><Citation>Cekanaviciute E., Yoo B.B., Runia T.F., Debelius J.W., Singh S., Nelson C.A., Kanner R., Bencosme Y., Lee Y.K., Hauser S.L., et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc. Natl. Acad. Sci. USA. 2017;114:10713&#x2013;10718. doi: 10.1073/pnas.1711235114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1711235114</ArticleId><ArticleId IdType="pmc">PMC5635915</ArticleId><ArticleId IdType="pubmed">28893978</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L.M., Maghzi A.H., Liu S., Tankou S.K., Dhang F.H., Willocq V., Song A., Was&#xe9;n C., Tauhid S., Chu R., et al. Gut Microbiome in Progressive Multiple Sclerosis. Ann. Neurol. 2021;89:1195&#x2013;1211. doi: 10.1002/ana.26084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26084</ArticleId><ArticleId IdType="pmc">PMC8132291</ArticleId><ArticleId IdType="pubmed">33876477</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangi S., Gandhi R., Cox L.M., Li N., von Glehn F., Yan R., Patel B., Mazzola M.A., Liu S., Glanz B.L., et al. Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 2016;7:12015. doi: 10.1038/ncomms12015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12015</ArticleId><ArticleId IdType="pmc">PMC4931233</ArticleId><ArticleId IdType="pubmed">27352007</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosorich I., Dalla-Costa G., Sorini C., Ferrarese R., Messina M.J., Dolpady J., Radice E., Mariani A., Testoni P.A., Canducci F., et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci. Adv. 2017;3:e1700492. doi: 10.1126/sciadv.1700492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1700492</ArticleId><ArticleId IdType="pmc">PMC5507635</ArticleId><ArticleId IdType="pubmed">28706993</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake S., Kim S., Suda W., Oshima K., Nakamura M., Matsuoka T., Chihara N., Tomita A., Sato W., Kim S.-W., et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS ONE. 2015;10:e0137429. doi: 10.1371/journal.pone.0137429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0137429</ArticleId><ArticleId IdType="pmc">PMC4569432</ArticleId><ArticleId IdType="pubmed">26367776</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Chia N., Kalari K.R., Yao J.Z., Novotna M., Paz Soldan M.M., Luckey D.H., Marietta E.V., Jeraldo P.R., Chen X. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep. 2016;6:28484. doi: 10.1038/srep28484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28484</ArticleId><ArticleId IdType="pmc">PMC4921909</ArticleId><ArticleId IdType="pubmed">27346372</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynders T., Devolder L., Valles-Colomer M., Van Remoortel A., Joossens M., De Keyser J., Nagels G., D&#x2019;hooghe M., Raes J. Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. Ann. Clin. Transl. Neurol. 2020;7:406&#x2013;419. doi: 10.1002/acn3.51004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51004</ArticleId><ArticleId IdType="pmc">PMC7187717</ArticleId><ArticleId IdType="pubmed">32162850</ArticleId></ArticleIdList></Reference><Reference><Citation>Melbye P., Olsson A., Hansen T.H., S&#xf8;ndergaard H.B., Bang Oturai A. Short-chain fatty acids and gut microbiota in multiple sclerosis. Acta Neurol. Scand. 2019;139:208&#x2013;219. doi: 10.1111/ane.13045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13045</ArticleId><ArticleId IdType="pubmed">30427062</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Zhan Y., Mariosa D., Larsson H., Almqvist C., Ingre C., Zagai U., Pawitan Y., Fang F. Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden. Eur. J. Neurol. 2019;26:1355&#x2013;1361. doi: 10.1111/ene.13986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13986</ArticleId><ArticleId IdType="pubmed">31087715</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Wang X., Yang S., Meng F., Wang X., Wei H., Chen T. Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing. Front. Microbiol. 2016;7:1479. doi: 10.3389/fmicb.2016.01479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01479</ArticleId><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia D., Bozzi Cionci N., Baffoni L., Amoruso A., Pane M., Mogna L., Gagg&#xec;a F., Lucenti M.A., Bersano E., Cantello R., et al. A prospective longitudinal study on themicrobiota composition in amyotrophic lateral sclerosis. BMC Med. 2020;18:153. doi: 10.1186/s12916-020-01607-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="pubmed">32546239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S.T., Restuadi R., McCrae A.F., Van Eijk R.P., Garton F., Henderson R.D., Wray N.R., McCombe P.A., Steyn F.J. Progression and survival of patients with motor neuron disease relative to their fecal microbiota. Amyotroph. Lateral Scler. Front. Degener. 2020;21:549&#x2013;562. doi: 10.1080/21678421.2020.1772825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1772825</ArticleId><ArticleId IdType="pubmed">32643435</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddy S.L., Giovannelli I., Sassani M., Cooper-Knock J., Snyder M.P., Segal E., Elinav E., Barker L.A., Shaw P.J., McDermott C.J. The gut microbiome: A key player in the complexity of amyotrophic lateral sclerosis (ALS) BMC Med. 2021;19:13. doi: 10.1186/s12916-020-01885-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01885-3</ArticleId><ArticleId IdType="pmc">PMC7816375</ArticleId><ArticleId IdType="pubmed">33468103</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerman A.L., Watts J.C., Aoyagi A., Giles K., Middleton L.T., Prusiner S.B. &#x3b1;-Synuclein: Multiple System Atrophy Prions. Cold Spring Harb. Perspect. Med. 2018;8:a024588. doi: 10.1101/cshperspect.a024588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024588</ArticleId><ArticleId IdType="pmc">PMC5561534</ArticleId><ArticleId IdType="pubmed">28213437</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishima T., Fujioka S., Kawazoe M., Inoue K., Arima H., Tsuboi Y. Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine. J. Pers Med. 2022;12:838. doi: 10.3390/jpm12050838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050838</ArticleId><ArticleId IdType="pmc">PMC9146870</ArticleId><ArticleId IdType="pubmed">35629260</ArticleId></ArticleIdList></Reference><Reference><Citation>Engen P.A., Dodiya H.B., Naqib A., Forsyth C.B., Green S.J., Voigt R.M., Kordower J.H., Mutlu E.A., Shannon K.M., Keshavarzian A. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. J. Park. Dis. 2017;7:331&#x2013;346. doi: 10.3233/JPD-160991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-160991</ArticleId><ArticleId IdType="pubmed">28234259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L., Zhou X., Wang C., Chen Z., Peng H., Hou X., Peng Y., Wang P., Li T., Yuan H., et al. Alterations of the Gut Microbiota in Multiple System Atrophy Patients. Front. Neurosci. 2019;13:1102. doi: 10.3389/fnins.2019.01102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01102</ArticleId><ArticleId IdType="pmc">PMC6813281</ArticleId><ArticleId IdType="pubmed">31680836</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhardt S., Mohajeri M.H. Changes of Colonic Bacterial Composition in Parkinson&#x2019;s Disease and Other Neurodegenerative Diseases. Nutrients. 2018;10:708. doi: 10.3390/nu10060708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10060708</ArticleId><ArticleId IdType="pmc">PMC6024871</ArticleId><ArticleId IdType="pubmed">29857583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong G., L&#xea; Cao K.-A., Judd L.M., Li S., Renoir T., Hannan A.J. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington&#x2019;s disease. Neurobiol. Dis. 2020;135:104268. doi: 10.1016/j.nbd.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.09.001</ArticleId><ArticleId IdType="pubmed">30194046</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Xu Y., Lin X., Zhen Z., Yi F., Guan H., Shi Q., Sun W., Yang A., Dong X., et al. Creutzfeldt-Jakob Disease: Alterations of Gut Microbiota. Front. Neurol. 2022;13:832599. doi: 10.3389/fneur.2022.832599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.832599</ArticleId><ArticleId IdType="pmc">PMC9051076</ArticleId><ArticleId IdType="pubmed">35493823</ArticleId></ArticleIdList></Reference><Reference><Citation>Gondalia S.V., Palombo E.A., Knowles S.R., Cox S.B., Meyer D., Austin D.W. Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res. 2012;5:419&#x2013;427. doi: 10.1002/aur.1253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aur.1253</ArticleId><ArticleId IdType="pubmed">22997101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D.-W., Adams J.B., Gregory A.C., Borody T., Chittick L., Fasano A., Khoruts A., Geis E., Maldonado J., McDonough-Means S., et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome. 2017;5:10. doi: 10.1186/s40168-016-0225-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0225-7</ArticleId><ArticleId IdType="pmc">PMC5264285</ArticleId><ArticleId IdType="pubmed">28122648</ArticleId></ArticleIdList></Reference><Reference><Citation>West K.A., Yin X., Rutherford E.M., Wee B., Choi J., Chrisman B.S., Dunlap K.L., Hannibal R.L., Hartono W., Lin M. Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: A step toward understanding patient subgroups. Sci. Rep. 2022;12:17034. doi: 10.1038/s41598-022-21327-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-21327-9</ArticleId><ArticleId IdType="pmc">PMC9554176</ArticleId><ArticleId IdType="pubmed">36220843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandini L.G., Curtin C., Phillips S., Anderson S.E., Maslin M., Must A. Changes in Food Selectivity in Children with Autism Spectrum Disorder. J. Autism Dev. Disord. 2017;47:439&#x2013;446. doi: 10.1007/s10803-016-2963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10803-016-2963-6</ArticleId><ArticleId IdType="pmc">PMC5310968</ArticleId><ArticleId IdType="pubmed">27866350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon G., Cruz N.J., Kang D.-W., Gandal M.J., Wang B., Kim Y.-M., Zink E.M., Casey C.P., Taylor B.C., Lane C.J. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177:1600&#x2013;1618.e17. doi: 10.1016/j.cell.2019.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.004</ArticleId><ArticleId IdType="pmc">PMC6993574</ArticleId><ArticleId IdType="pubmed">31150625</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies C., Mishra D., Eshraghi R.S., Mittal J., Sinha R., Bulut E., Mittal R., Eshraghi A.A. Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: A systematic review. Neurosci. Biobehav. Rev. 2021;128:549&#x2013;557. doi: 10.1016/j.neubiorev.2021.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2021.07.001</ArticleId><ArticleId IdType="pubmed">34271306</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Yang J., Zhang J., Liang C., Wang Y., Chen B., Zhao C., Wang J., Zhang G., Zhao D., et al. Correlation of Gut Microbiome Between ASD Children and Mothers and Potential Biomarkers for Risk Assessment. Genom. Proteom. Bioinform. 2019;17:26&#x2013;38. doi: 10.1016/j.gpb.2019.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2019.01.002</ArticleId><ArticleId IdType="pmc">PMC6520911</ArticleId><ArticleId IdType="pubmed">31026579</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowlie G., Cohen N., Ming X. The Perturbance of Microbiome and Gut-Brain Axis in Autism Spectrum Disorders. Int. J. Mol. Sci. 2018;19:2251. doi: 10.3390/ijms19082251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082251</ArticleId><ArticleId IdType="pmc">PMC6121241</ArticleId><ArticleId IdType="pubmed">30071612</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Rezende R.M., Moreira T.G., Tankou S.K., Cox L.M., Wu M., Song A., Dhang F.H., Wei Z., Costamagna G. Oral administration of miR-30d from feces of MS patients suppresses MS-like symptoms in mice by expanding Akkermansia muciniphila. Cell Host Microbe. 2019;26:779&#x2013;794.e8. doi: 10.1016/j.chom.2019.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.10.008</ArticleId><ArticleId IdType="pmc">PMC6948921</ArticleId><ArticleId IdType="pubmed">31784260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte E.R. Autism and Clostridium tetani. Med. Hypotheses. 1998;51:133&#x2013;144. doi: 10.1016/s0306-9877(98)90107-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0306-9877(98)90107-4</ArticleId><ArticleId IdType="pubmed">9881820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeid&#xe1;n-Chuli&#xe1; F., Fonseca Moreira J. Clostridium Bacteria and its Impact in Autism Research: Thinking &#x201c;Outside The Box&#x201d; of Neuroscience. Med. Hypotheses. 2013;51:133&#x2013;144. doi: 10.4172/2375-4427.1000101.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2375-4427.1000101</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshammari M.K., AlKhulaifi M.M., Al Farraj D.A., Somily A.M., Albarrag A.M. Incidence of Clostridium perfringens and its toxin genes in the gut of children with autism spectrum disorder. Anaerobe. 2020;61:102114. doi: 10.1016/j.anaerobe.2019.102114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2019.102114</ArticleId><ArticleId IdType="pubmed">31704282</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Yu Y.-M., Zhang Y.-q., Zhang J., Lu N., Liu N. Hydrogen breath test to detect small intestinal bacterial overgrowth: A prevalence case&#x2013;control study in autism. Eur. Child Adolesc. Psychiatry. 2018;27:233&#x2013;240. doi: 10.1007/s00787-017-1039-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00787-017-1039-2</ArticleId><ArticleId IdType="pubmed">28799094</ArticleId></ArticleIdList></Reference><Reference><Citation>Checa-Ros A., Jer&#xe9;z-Calero A., Molina-Carballo A., Campoy C., Mu&#xf1;oz-Hoyos A. Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients. 2021;13:249. doi: 10.3390/nu13010249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13010249</ArticleId><ArticleId IdType="pmc">PMC7830868</ArticleId><ArticleId IdType="pubmed">33467150</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukmajaya A.C., Lusida M.I., Soetjipto , Setiawati Y. Systematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD) Ann. Gen. Psychiatry. 2021;20:12. doi: 10.1186/s12991-021-00330-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12991-021-00330-w</ArticleId><ArticleId IdType="pmc">PMC7888126</ArticleId><ArticleId IdType="pubmed">33593384</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarts E., Ederveen T.H., Naaijen J., Zwiers M.P., Boekhorst J., Timmerman H.M., Smeekens S.P., Netea M.G., Buitelaar J.K., Franke B. Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS ONE. 2017;12:e0183509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5581161</ArticleId><ArticleId IdType="pubmed">28863139</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H.-y., Zhou Y.-y., Zhou G.-l., Li Y.-c., Yuan J., Li X.-h., Ruan B. Gut microbiota profiles in treatment-na&#xef;ve children with attention deficit hyperactivity disorder. Behav. Brain Res. 2018;347:408&#x2013;413. doi: 10.1016/j.bbr.2018.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2018.03.036</ArticleId><ArticleId IdType="pubmed">29580894</ArticleId></ArticleIdList></Reference><Reference><Citation>Szopinska-Tokov J., Dam S., Naaijen J., Konstanti P., Rommelse N., Belzer C., Buitelaar J., Franke B., Bloemendaal M., Aarts E. Investigating the gut microbiota composition of individuals with attention-deficit/hyperactivity disorder and association with symptoms. Microorganisms. 2020;8:406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7143990</ArticleId><ArticleId IdType="pubmed">32183143</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.-Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.-C., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakili K., Fathi M., Yaghoobpoor S., Sayehmiri F., Nazerian Y., Nazerian A., Mohamadkhani A., Khodabakhsh P., R&#xe9;us G.Z., Hajibeygi R., et al. The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature. Front. Cell. Infect. Microbiol. 2022;12:983089. doi: 10.3389/fcimb.2022.983089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.983089</ArticleId><ArticleId IdType="pmc">PMC9815719</ArticleId><ArticleId IdType="pubmed">36619768</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID syndrome-associated brain fog. J. Med. Virol. 2022;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers P. Long Covid and Neurodegenerative Disease. Preprints. 2023 doi: 10.20944/preprints202302.0027.v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202302.0027.v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilpert K., Mikut R. Is There a Connection Between Gut Microbiome Dysbiosis Occurring in COVID-19 Patients and Post-COVID-19 Symptoms? Front. Microbiol. 2021;12:732838. doi: 10.3389/fmicb.2021.732838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.732838</ArticleId><ArticleId IdType="pmc">PMC8485028</ArticleId><ArticleId IdType="pubmed">34603261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C.-Y., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., Lu H., Shi D., Guo J., Wu W.-R., Yang Y., Li Y., Xu K.-J. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2022;71:222&#x2013;225. doi: 10.1136/gutjnl-2021-324090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L., Goodrich J.K., Walters W.A., Levine S.M., Ley R.E., Hanson M.R. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2016;4:30. doi: 10.1186/s40168-016-0171-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0171-4</ArticleId><ArticleId IdType="pmc">PMC4918027</ArticleId><ArticleId IdType="pubmed">27338587</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig R.S., Albrich W.C., Kahlert C.R., Bahr L.S., L&#xf6;ber U., Vernazza P., Scheibenbogen C., Forslund S.K. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) Front. Immunol. 2022;12:628741. doi: 10.3389/fimmu.2021.628741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.628741</ArticleId><ArticleId IdType="pmc">PMC8761622</ArticleId><ArticleId IdType="pubmed">35046929</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front. Pediatr. 2019;7:12. doi: 10.3389/fped.2019.00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xe9;mont M., Coomans D., Massart S., De Meirleir K. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. Anaerobe. 2013;22:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">23791918</ArticleId></ArticleIdList></Reference><Reference><Citation>Newberry F., Hsieh S.-Y., Wileman T., Carding S.R. Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? Clin. Sci. 2018;132:523&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5843715</ArticleId><ArticleId IdType="pubmed">29523751</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson B. Introduction to the Journal of Physiology&#x2019;s Special edition on neurological channelopathies. J. Physiol. 2010;588:1821&#x2013;1822. doi: 10.1113/jphysiol.2010.191114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2010.191114</ArticleId><ArticleId IdType="pmc">PMC2901969</ArticleId><ArticleId IdType="pubmed">20516349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Q., Cai M., Xiao B., Zhan Q., Zeng C. The Microbiota-Gut-Brain Axis and Epilepsy. Cell Mol. Neurobiol. 2022;42:439&#x2013;453. doi: 10.1007/s10571-021-01130-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-021-01130-2</ArticleId><ArticleId IdType="pubmed">34279746</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaral F., Sachs D., Costa V., Fagundes C., Cisalpino D., Cunha T., Ferreira S., Cunha F., Silva T., Nicoli J. Commensal microbiota is fundamental for the development of inflammatory pain. Proc. Natl. Acad. Sci. USA. 2008;105:2193&#x2013;2197. doi: 10.1073/pnas.0711891105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0711891105</ArticleId><ArticleId IdType="pmc">PMC2538897</ArticleId><ArticleId IdType="pubmed">18268332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin B., Wang Y., Zhang P., Yuan Y., Zhang Y., Chen G. Gut microbiota regulates neuropathic pain: Potential mechanisms and therapeutic strategy. J. Headache Pain. 2020;21:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7433133</ArticleId><ArticleId IdType="pubmed">32807072</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo R., Chen L.-H., Xing C., Liu T. Pain regulation by gut microbiota: Molecular mechanisms and therapeutic potential. Br. J. Anaesth. 2019;123:637&#x2013;654. doi: 10.1016/j.bja.2019.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.07.026</ArticleId><ArticleId IdType="pubmed">31551115</ArticleId></ArticleIdList></Reference><Reference><Citation>Belrose J.C., Noppens R.R. Anesthesiology and cognitive impairment: A narrative review of current clinical literature. BMC Anesthesiol. 2019;19:241. doi: 10.1186/s12871-019-0903-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0903-7</ArticleId><ArticleId IdType="pmc">PMC6933922</ArticleId><ArticleId IdType="pubmed">31881996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugita S., Tahir P., Kinjo S. The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction-A systematic review. PLoS ONE. 2023;18:e0281049. doi: 10.1371/journal.pone.0281049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281049</ArticleId><ArticleId IdType="pmc">PMC9904456</ArticleId><ArticleId IdType="pubmed">36749772</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Hu Y., Yan E., Zhan G., Liu C., Yang C. Perioperative neurocognitive dysfunction: Thinking from the gut? Aging. 2020;12:15797. doi: 10.18632/aging.103738.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103738</ArticleId><ArticleId IdType="pmc">PMC7467368</ArticleId><ArticleId IdType="pubmed">32805716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan G., Hua D., Huang N., Wang Y., Li S., Zhou Z., Yang N., Jiang R., Zhu B., Yang L. Anesthesia and surgery induce cognitive dysfunction in elderly male mice: The role of gut microbiota. Aging. 2019;11:1778. doi: 10.18632/aging.101871.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101871</ArticleId><ArticleId IdType="pmc">PMC6461176</ArticleId><ArticleId IdType="pubmed">30904902</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L., Li J., Zhang C., Liu D.-X. Gut microbiota: A new player in the pathogenesis of perioperative neurocognitive disorder? Ibrain. 2021;7:37&#x2013;43. doi: 10.1002/j.2769-2795.2021.tb00063.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.2769-2795.2021.tb00063.x</ArticleId><ArticleId IdType="pmc">PMC10529199</ArticleId><ArticleId IdType="pubmed">37786871</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Yin X., Li J., Cao Y., Wang Y., Mu W., Zhuo Z., Chen L., Zhang Z., Qu X., et al. Preoperative intestinal microbiome and metabolome in elderly patients with delayed neurocognitive recovery. Anaesth. Crit. Care Pain Med. 2022;41:101140. doi: 10.1016/j.accpm.2022.101140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2022.101140</ArticleId><ArticleId IdType="pubmed">35963525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubomski M., Davis R.L., Sue C.M. The gut microbiota: A novel therapeutic target in Parkinson&#x2019;s disease? Park. Relat. Disord. 2019;66:265&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">31445904</ArticleId></ArticleIdList></Reference><Reference><Citation>DuPont H.L., Suescun J., Jiang Z.-D., Brown E.L., Iqbal T., Alexander A.S., DuPont A.W., Newark M., Essigmann H.T., Schiess M.C. Microbiome characterization and reversal of dysbiosis in Parkinson&#x2019;s disease by Fecal Microbiota Transplantation (1825) Neurology. 2020;94:1825.</Citation></Reference><Reference><Citation>Xue L.J., Yang X.Z., Tong Q., Shen P., Ma S.J., Wu S.N., Zheng J.L., Wang H.G. Fecal microbiota transplantation therapy for Parkinson&#x2019;s disease: A preliminary study. Medicine. 2020;99:e22035. doi: 10.1097/MD.0000000000022035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000022035</ArticleId><ArticleId IdType="pmc">PMC7458210</ArticleId><ArticleId IdType="pubmed">32871960</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraeuter A.-K., Phillips R., Sarnyai Z. Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2020;101:109913. doi: 10.1016/j.pnpbp.2020.109913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.109913</ArticleId><ArticleId IdType="pubmed">32151695</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli V., d&#x2019;Angelo M., Quintiliani M., Benedetti E., Cifone M.G., Cimini A. The emerging role of probiotics in neurodegenerative diseases: New hope for Parkinson&#x2019;s disease? Neural Regen Res. 2021;16:628&#x2013;634. doi: 10.4103/1673-5374.295270.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.295270</ArticleId><ArticleId IdType="pmc">PMC8067943</ArticleId><ArticleId IdType="pubmed">33063712</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicknell B., Liebert A., Johnstone D., Kiat H. Photobiomodulation of the microbiome: Implications for metabolic and inflammatory diseases. Lasers Med. Sci. 2018;34:317&#x2013;327. doi: 10.1007/s10103-018-2594-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-018-2594-6</ArticleId><ArticleId IdType="pubmed">30074108</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Brink A.C., Brouwer-Brolsma E.M., Berendsen A.A.M., van de Rest O. The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diets Are Associated with Less Cognitive Decline and a Lower Risk of Alzheimer&#x2019;s Disease&#x2014;A Review. Adv. Nutr. 2019;10:1040&#x2013;1065. doi: 10.1093/advances/nmz054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz054</ArticleId><ArticleId IdType="pmc">PMC6855954</ArticleId><ArticleId IdType="pubmed">31209456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheirouri S., Alizadeh M. MIND diet and cognitive performance in older adults: A systematic review. Crit. Rev. Food Sci. Nutr. 2022;62:8059&#x2013;8077. doi: 10.1080/10408398.2021.1925220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2021.1925220</ArticleId><ArticleId IdType="pubmed">33989093</ArticleId></ArticleIdList></Reference><Reference><Citation>de Crom T.O.E., Mooldijk S.S., Ikram M.K., Ikram M.A., Voortman T. MIND diet and the risk of dementia: A population-based study. Alzheimer&#x2019;s Res. Ther. 2022;14:8. doi: 10.1186/s13195-022-00957-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-00957-1</ArticleId><ArticleId IdType="pmc">PMC8756695</ArticleId><ArticleId IdType="pubmed">35022067</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal P., Leurgans S.E., Agrawal S., Aggarwal N., Cherian I.J., James B.D., Dhana K., Barnes L.L., Bennett D.A., Schneider J.A. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023;10:e2259&#x2013;e2268. doi: 10.1212/WNL.0000000000207176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207176</ArticleId><ArticleId IdType="pmc">PMC10259273</ArticleId><ArticleId IdType="pubmed">36889921</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Tuck C., Gibson P.R., Chey W.D. The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation. Am. J. Gastroenterol. 2022;117:947&#x2013;957. doi: 10.14309/ajg.0000000000001767.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001767</ArticleId><ArticleId IdType="pmc">PMC9169760</ArticleId><ArticleId IdType="pubmed">35435179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chicco F., Magr&#xec; S., Cingolani A., Paduano D., Pesenti M., Zara F., Tumbarello F., Urru E., Melis A., Casula L., et al. Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflamm. Bowel Dis. 2020;27:1&#x2013;9. doi: 10.1093/ibd/izaa097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa097</ArticleId><ArticleId IdType="pmc">PMC7737160</ArticleId><ArticleId IdType="pubmed">32440680</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchianti Diamanti A., Panebianco C., Salerno G., Di Rosa R., Salemi S., Sorgi M.L., Meneguzzi G., Mariani M.B., Rai A., Iacono D. Impact of Mediterranean diet on disease activity and gut microbiota composition of rheumatoid arthritis patients. Microorganisms. 2020;8:1989. doi: 10.3390/microorganisms8121989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8121989</ArticleId><ArticleId IdType="pmc">PMC7764882</ArticleId><ArticleId IdType="pubmed">33327432</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggi S., Ticinesi A., Limongi F., Noale M., Ecarnot F. The role of nutrition and the Mediterranean diet on the trajectories of cognitive decline. Exp. Gerontol. 2023;173:112110. doi: 10.1016/j.exger.2023.112110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2023.112110</ArticleId><ArticleId IdType="pubmed">36720373</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade A.T., Elias M.F., Murphy K.J. Adherence to a Mediterranean diet is associated with cognitive function in an older non-Mediterranean sample: Findings from the Maine-Syracuse Longitudinal Study. Nutr. Neurosci. 2021;24:542&#x2013;553. doi: 10.1080/1028415X.2019.1655201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2019.1655201</ArticleId><ArticleId IdType="pubmed">31432770</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegelmaier T., Lebbing M., Duscha A., Tomaske L., T&#xf6;nges L., Holm J.B., Bj&#xf8;rn Nielsen H., Gatermann S.G., Przuntek H., Haghikia A. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson&#x2019;s Disease. Cells. 2020;9:376. doi: 10.3390/cells9020376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020376</ArticleId><ArticleId IdType="pmc">PMC7072275</ArticleId><ArticleId IdType="pubmed">32041265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhana K., James B.D., Agarwal P., Aggarwal N.T., Cherian L.J., Leurgans S.E., Barnes L.L., Bennett D.A., Schneider J.A. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J. Alzheimer&#x2019;s Dis. 2021;83:683&#x2013;692. doi: 10.3233/JAD-210107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210107</ArticleId><ArticleId IdType="pmc">PMC8480203</ArticleId><ArticleId IdType="pubmed">34334393</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips M.C.L., Deprez L.M., Mortimer G.M.N., Murtagh D.K.J., McCoy S., Mylchreest R., Gilbertson L.J., Clark K.M., Simpson P.V., McManus E.J., et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Res. Ther. 2021;13:51. doi: 10.1186/s13195-021-00783-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00783-x</ArticleId><ArticleId IdType="pmc">PMC7901512</ArticleId><ArticleId IdType="pubmed">33622392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Fan D., Huang J.-l., Zuo T. The gut microbiome: Linking dietary fiber to inflammatory diseases. Med. Microecol. 2022;14:100070. doi: 10.1016/j.medmic.2022.100070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmic.2022.100070</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan K., Staudacher H.M. Fibre is good for the microbiome: But what is the evidence? Lancet Gastroenterol. Hepatol. 2022;7:988. doi: 10.1016/S2468-1253(22)00310-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(22)00310-7</ArticleId><ArticleId IdType="pubmed">36208636</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffington S.A., Di Prisco G.V., Auchtung T.A., Ajami N.J., Petrosino J.F., Costa-Mattioli M. Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell. 2016;165:1762&#x2013;1775. doi: 10.1016/j.cell.2016.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.06.001</ArticleId><ArticleId IdType="pmc">PMC5102250</ArticleId><ArticleId IdType="pubmed">27315483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman J.D., Yanckello L.M., Chlipala G., Hammond T.C., McCulloch S.D., Parikh I., Sun S., Morganti J.M., Green S.J., Lin A.L. Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model. PLoS ONE. 2019;14:e0221828. doi: 10.1371/journal.pone.0221828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221828</ArticleId><ArticleId IdType="pmc">PMC6713395</ArticleId><ArticleId IdType="pubmed">31461505</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Monter C., &#xc1;lvarez-Arce A., Nu&#xf1;o-Lambarri N., Escalona-N&#xe1;ndez I., Ju&#xe1;rez-Hern&#xe1;ndez E., Ch&#xe1;vez-Tapia N.C., Uribe M., Barbero-Becerra V.J. Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level. Int. J. Mol. Sci. 2022;23:991. doi: 10.3390/ijms23020991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020991</ArticleId><ArticleId IdType="pmc">PMC8782000</ArticleId><ArticleId IdType="pubmed">35055177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalanka J., Major G., Murray K., Singh G., Nowak A., Kurtz C., Silos-Santiago I., Johnston J.M., de Vos W.M., Spiller R. The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls. Int. J. Mol. Sci. 2019;20:433. doi: 10.3390/ijms20020433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020433</ArticleId><ArticleId IdType="pmc">PMC6358997</ArticleId><ArticleId IdType="pubmed">30669509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretin A., Zou J., San Yeoh B., Ngo V.L., Winer S., Winer D.A., Reddivari L., Pellizzon M., Walters W.A., Patterson A.D., et al. Psyllium fiber protects against colitis via activation of bile acid sensor fxr. Cell. Mol. Gastroenterol. Hepatol. 2023;15:1421&#x2013;1442. doi: 10.1016/j.jcmgh.2023.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2023.02.007</ArticleId><ArticleId IdType="pmc">PMC10148163</ArticleId><ArticleId IdType="pubmed">36828279</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa M.Y.A. Effect of Feeding Psyllium Husk (Plantago Ovata) Herbs on Rats suffering from Hyperglycemia. J. Specif. Educ. Stud. Res. 2017;3:564&#x2013;591. doi: 10.21608/jsezu.2017.238369.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/jsezu.2017.238369</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bastard Q., Chapelet G., Javaudin F., Lepelletier D., Batard E., Montassier E. The effects of inulin on gut microbial composition: A systematic review of evidence from human studies. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:403&#x2013;413. doi: 10.1007/s10096-019-03721-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-019-03721-w</ArticleId><ArticleId IdType="pubmed">31707507</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipour Nosrani E., Tamtaji O.R., Alibolandi Z., Sarkar P., Ghazanfari M., Azami Tameh A., Taghizadeh M., Banikazemi Z., Hadavi R., Naderi Taheri M. Neuroprotective effects of probiotics bacteria on animal model of Parkinson&#x2019;s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. J. Immunoass. Immunochem. 2021;42:106&#x2013;120. doi: 10.1080/15321819.2020.1833917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2020.1833917</ArticleId><ArticleId IdType="pubmed">33078659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H.-F., Shen L. Probiotics as potential therapeutic options for Alzheimer&#x2019;s disease. Appl. Microbiol. Biotechnol. 2021;105:7721&#x2013;7730. doi: 10.1007/s00253-021-11607-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-021-11607-1</ArticleId><ArticleId IdType="pubmed">34596721</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaei H., Sedighi S., Kouchaki E., Barati E., Dadgostar E., Aschner M., Tamtaji O.R. Probiotics and the Treatment of Parkinson&#x2019;s Disease: An Update. Cell. Mol. Neurobiol. 2021;42:2449&#x2013;2457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770674</ArticleId><ArticleId IdType="pubmed">34283340</ArticleId></ArticleIdList></Reference><Reference><Citation>Divyashri G., Prapulla S. Animal Models Used for Studying the Benefits of Probiotics in Neurodegeneration. In: Deol P.K., Sandu S.K., editors. Probiotic Research in Therapeutics: Probiotics in Neurodegenerative Disorders. Volume 4. Springer Nature; Singapore: 2022. pp. 237&#x2013;254.</Citation></Reference><Reference><Citation>Schaly S., Prakash S. Combating the Sustained Inflammation Involved in Aging and Neurodegenerative Diseases with Probiotics. In: Marotta F., editor. Gut Microbiota in Aging and Chronic Diseases. Springer Nature; Cham, Switzerland: 2023. pp. 193&#x2013;213.</Citation></Reference><Reference><Citation>Mint&#xe1;l K., T&#xf3;th A., Hormay E., Kov&#xe1;cs A., L&#xe1;szl&#xf3; K., Bufa A., Marosv&#xf6;lgyi T., Kocsis B., Varga A., Vizv&#xe1;ri Z. Novel probiotic treatment of autism spectrum disorder associated social behavioral symptoms in two rodent models. Sci. Rep. 2022;12:5399. doi: 10.1038/s41598-022-09350-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09350-2</ArticleId><ArticleId IdType="pmc">PMC8967893</ArticleId><ArticleId IdType="pubmed">35354898</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell L.K., Davies P.S. Pre-and probiotics in the management of children with autism and gut issues: A review of the current evidence. Eur. J. Clin. Nutr. 2022;76:913&#x2013;921. doi: 10.1038/s41430-021-01027-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-021-01027-9</ArticleId><ArticleId IdType="pubmed">34675402</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli V., d&#x2019;Angelo M., Lombardi F., Alfonsetti M., Antonosante A., Catanesi M., Benedetti E., Palumbo P., Cifone M.G., Giordano A., et al. Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson&#x2019;s disease models. Aging. 2020;12:4641&#x2013;4659. doi: 10.18632/aging.102927.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102927</ArticleId><ArticleId IdType="pmc">PMC7093198</ArticleId><ArticleId IdType="pubmed">32155131</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu D., Xue L., Li H., Du J. Probiotics modulate the microbiota&#x2013;gut&#x2013;brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm. Sin. B. 2020;10:475&#x2013;487. doi: 10.1016/j.apsb.2019.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2019.07.001</ArticleId><ArticleId IdType="pmc">PMC7049608</ArticleId><ArticleId IdType="pubmed">32140393</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Chu C., Wu C., Wang C., Zhang C., Li T., Zhai Q., Yu L., Tian F., Chen W. Efficacy of probiotics in multiple sclerosis: A systematic review of preclinical trials and meta-analysis of randomized controlled trials. Food Funct. 2021;12:2354&#x2013;2377. doi: 10.1039/D0FO03203D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0FO03203D</ArticleId><ArticleId IdType="pubmed">33629669</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E., Bashiardes S., Shapiro H., Rothschild D., Mor U., Dori-Bachash M., Kleimeyer C., Moresi C., Harnik Y., Zur M. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabouy L., Getselter D., Ziv O., Karpuj M., Tabouy T., Lukic I., Maayouf R., Werbner N., Ben-Amram H., Nuriel-Ohayon M. Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders. Brain Behav. Immun. 2018;73:310&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">29787855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong C., Gao R., Yan X., Huang L., Qin H. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. Nutrition. 2019;60:175&#x2013;184. doi: 10.1016/j.nut.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2018.10.002</ArticleId><ArticleId IdType="pubmed">30611080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., Bu F., Chen T., Shi G., Yuan X., Feng Z., Duan Z., Wang R., Zhang S., Wang Q. A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress&#x2013;induced depressive-like behavior in mice by regulating gut microbiota and metabolites. Appl. Microbiol. Biotechnol. 2021;105:8411&#x2013;8426. doi: 10.1007/s00253-021-11622-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-021-11622-2</ArticleId><ArticleId IdType="pubmed">34617139</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari E., Asemi Z., Daneshvar Kakhaki R., Bahmani F., Kouchaki E., Tamtaji O.R., Hamidi G.A., Salami M. Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer&#x2019;s Disease: A Randomized, Double-Blind and Controlled Trial. Front. Aging Neurosci. 2016;8:256. doi: 10.3389/fnagi.2016.00256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00256</ArticleId><ArticleId IdType="pmc">PMC5105117</ArticleId><ArticleId IdType="pubmed">27891089</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamtaji O.R., Heidari-Soureshjani R., Mirhosseini N., Kouchaki E., Bahmani F., Aghadavod E., Tajabadi-Ebrahimi M., Asemi Z. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer&#x2019;s disease: A randomized, double-blind, controlled trial. Clin. Nutr. 2019;38:2569&#x2013;2575. doi: 10.1016/j.clnu.2018.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2018.11.034</ArticleId><ArticleId IdType="pubmed">30642737</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang Y.-H., Park S., Paik J.-W., Chae S.-W., Kim D.-H., Jeong D.-G., Ha E., Kim M., Hong G., Park S.-H., et al. Efficacy and Safety of Lactobacillus Plantarum C29-Fermented Soybean (DW2009) in Individuals with Mild Cognitive Impairment: A 12-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2019;11:305. doi: 10.3390/nu11020305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11020305</ArticleId><ArticleId IdType="pmc">PMC6412773</ArticleId><ArticleId IdType="pubmed">30717153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamtaji O.R., Taghizadeh M., Kakhaki R.D., Kouchaki E., Bahmani F., Borzabadi S., Oryan S., Mafi A., Asemi Z. Clinical and metabolic response to probiotic administration in people with Parkinson&#x2019;s disease: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2019;38:1031&#x2013;1035. doi: 10.1016/j.clnu.2018.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2018.05.018</ArticleId><ArticleId IdType="pubmed">29891223</ArticleId></ArticleIdList></Reference><Reference><Citation>Rianda D., Agustina R., Setiawan E., Manikam N. Effect of probiotic supplementation on cognitive function in children and adolescents: A systematic review of randomised trials. Benef. Microbes. 2019;10:873&#x2013;882. doi: 10.3920/BM2019.0068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2019.0068</ArticleId><ArticleId IdType="pubmed">31965841</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe4;rtty A., Kalliom&#xe4;ki M., Wacklin P., Salminen S., Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: A randomized trial. Pediatr. Res. 2015;77:823&#x2013;828. doi: 10.1038/pr.2015.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2015.51</ArticleId><ArticleId IdType="pubmed">25760553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q.X., Loke W., Venkatanarayanan N., Lim D.Y., Soh A.Y.S., Yeo W.S. A Systematic Review of the Role of Prebiotics and Probiotics in Autism Spectrum Disorders. Medicina. 2019;55:129. doi: 10.3390/medicina55050129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina55050129</ArticleId><ArticleId IdType="pmc">PMC6571640</ArticleId><ArticleId IdType="pubmed">31083360</ArticleId></ArticleIdList></Reference><Reference><Citation>Quraishi M.N., Widlak M., Bhala N.a., Moore D., Price M., Sharma N., Iqbal T. Systematic review with meta-analysis: The efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment. Pharmacol. Ther. 2017;46:479&#x2013;493. doi: 10.1111/apt.14201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.14201</ArticleId><ArticleId IdType="pubmed">28707337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullish B.H., Quraishi M.N., Segal J.P., McCune V.L., Baxter M., Marsden G.L., Moore D.J., Colville A., Bhala N., Iqbal T.H., et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67:1920&#x2013;1941. doi: 10.1136/gutjnl-2018-316818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-316818</ArticleId><ArticleId IdType="pubmed">30154172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianiro G., Bibb&#xf2; S., Scaldaferri F., Gasbarrini A., Cammarota G. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement. Medicine. 2014;93:e97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4616323</ArticleId><ArticleId IdType="pubmed">25340496</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Chen V.L., Steiner C.A., Berinstein J.A., Eswaran S., Waljee A.K., Higgins P.D., Owyang C. Efficacy of fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis. Am. J. Gastroenterol. 2019;114:1043. doi: 10.14309/ajg.0000000000000198.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000198</ArticleId><ArticleId IdType="pmc">PMC7257434</ArticleId><ArticleId IdType="pubmed">30908299</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Salhy M., Hatlebakk J.G., Gilja O.H., Kristoffersen A.B., Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69:859&#x2013;867. doi: 10.1136/gutjnl-2019-319630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2019-319630</ArticleId><ArticleId IdType="pmc">PMC7229896</ArticleId><ArticleId IdType="pubmed">31852769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol H., Landman C., Seksik P., Berard L., Montil M., Nion-Larmurier I., Bourrier A., Le Gall G., Lalande V., De Rougemont A. Fecal microbiota transplantation to maintain remission in Crohn&#x2019;s disease: A pilot randomized controlled study. Microbiome. 2020;8:12. doi: 10.1186/s40168-020-0792-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-020-0792-5</ArticleId><ArticleId IdType="pmc">PMC6998149</ArticleId><ArticleId IdType="pubmed">32014035</ArticleId></ArticleIdList></Reference><Reference><Citation>Moayyedi P., Surette M.G., Kim P.T., Libertucci J., Wolfe M., Onischi C., Armstrong D., Marshall J.K., Kassam Z., Reinisch W. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102&#x2013;109.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25857665</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrieze A., Van Nood E., Holleman F., Saloj&#xe4;rvi J., Kootte R.S., Bartelsman J.F., Dallinga&#x2013;Thie G.M., Ackermans M.T., Serlie M.J., Oozeer R. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913&#x2013;916.e917. doi: 10.1053/j.gastro.2012.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2012.06.031</ArticleId><ArticleId IdType="pubmed">22728514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Zhang B., Chen F., Xia R., Zhu D., Chen B., Lin A., Zheng C., Hou D., Li X. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study. Front. Cell. Infect. Microbiol. 2023;12:1929. doi: 10.3389/fcimb.2022.1089991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1089991</ArticleId><ArticleId IdType="pmc">PMC9872724</ArticleId><ArticleId IdType="pubmed">36704100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu E.W., Gao L., Stastka P., Cheney M.C., Mahabamunuge J., Torres Soto M., Ford C.B., Bryant J.A., Henn M.R., Hohmann E.L. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial. PLoS Med. 2020;17:e1003051. doi: 10.1371/journal.pmed.1003051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003051</ArticleId><ArticleId IdType="pmc">PMC7062239</ArticleId><ArticleId IdType="pubmed">32150549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kootte R.S., Levin E., Saloj&#xe4;rvi J., Smits L.P., Hartstra A.V., Udayappan S.D., Hermes G., Bouter K.E., Koopen A.M., Holst J.J. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 2017;26:611&#x2013;619.e6. doi: 10.1016/j.cmet.2017.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.09.008</ArticleId><ArticleId IdType="pubmed">28978426</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Lu Y., Yan Y., Tian S., Zheng D., Leng D., Wang C., Jiao J., Wang Z., Bai Y. Promising treatment for type 2 diabetes: Fecal microbiota transplantation reverses insulin resistance and impaired islets. Front. Cell. Infect. Microbiol. 2020;9:455. doi: 10.3389/fcimb.2019.00455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00455</ArticleId><ArticleId IdType="pmc">PMC6979041</ArticleId><ArticleId IdType="pubmed">32010641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhang S., Borody T.J., Zhang F. Encyclopedia of fecal microbiota transplantation: A review of effectiveness in the treatment of 85 diseases. Chin. Med. J. 2022;135:1927&#x2013;1939. doi: 10.1097/CM9.0000000000002339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000002339</ArticleId><ArticleId IdType="pmc">PMC9746749</ArticleId><ArticleId IdType="pubmed">36103991</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson J.-A.T., Holsinger R.M.D. The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review. Int. J. Mol. Sci. 2023;24:1001. doi: 10.3390/ijms24021001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021001</ArticleId><ArticleId IdType="pmc">PMC9864694</ArticleId><ArticleId IdType="pubmed">36674517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan S. Rapid improvement in Alzheimer&#x2019;s disease symptoms following fecal microbiota transplantation: A case report. J. Int. Med. Res. 2020;48:0300060520925930. doi: 10.1177/0300060520925930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060520925930</ArticleId><ArticleId IdType="pmc">PMC7328362</ArticleId><ArticleId IdType="pubmed">32600151</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.-H., Lee J.H., Shin J., Kim J.-S., Cha B., Lee S., Kwon K.S., Shin Y.W., Choi S.H. Cognitive function improvement after fecal microbiota transplantation in Alzheimer&#x2019;s dementia patient: A case report. Curr. Med. Res. Opin. 2021;37:1739&#x2013;1744. doi: 10.1080/03007995.2021.1957807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2021.1957807</ArticleId><ArticleId IdType="pubmed">34289768</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Xu H., Luo Q., He J., Li M., Chen H., Tang W., Nie Y., Zhou Y. Fecal microbiota transplantation to treat Parkinson&#x2019;s disease with constipation: A case report. Medicine. 2019;98:e16163. doi: 10.1097/MD.0000000000016163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000016163</ArticleId><ArticleId IdType="pmc">PMC6616439</ArticleId><ArticleId IdType="pubmed">31261545</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal A., Zlotnik Y., Moyal-Atias K., Abuhasira R., Ifergane G. Fecal microbiota transplant as a potential treatment for Parkinson&#x2019;s disease&#x2013;A case series. Clin. Neurol. Neurosurg. 2021;207:106791. doi: 10.1016/j.clineuro.2021.106791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2021.106791</ArticleId><ArticleId IdType="pubmed">34237681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuai X.-Y., Yao X.-H., Xu L.-J., Zhou Y.-Q., Zhang L.-P., Liu Y., Pei S.-F., Zhou C.-L. Evaluation of fecal microbiota transplantation in Parkinson&#x2019;s disease patients with constipation. Microb. Cell Factories. 2021;20:98. doi: 10.1186/s12934-021-01589-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-021-01589-0</ArticleId><ArticleId IdType="pmc">PMC8120701</ArticleId><ArticleId IdType="pubmed">33985520</ArticleId></ArticleIdList></Reference><Reference><Citation>Borody T., Leis S., Campbell J., Torres M., Nowak A. Fecal microbiota transplantation (FMT) in multiple sclerosis (MS): 942. Off. J. Am. Coll. Gastroenterol. ACG. 2011;106:S352. doi: 10.14309/00000434-201110002-00942.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/00000434-201110002-00942</ArticleId></ArticleIdList></Reference><Reference><Citation>Makkawi S., Camara-Lemarroy C., Metz L. Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS. Neurol. -Neuroimmunol. Neuroinflamm. 2018;5:e459. doi: 10.1212/NXI.0000000000000459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000459</ArticleId><ArticleId IdType="pmc">PMC5882466</ArticleId><ArticleId IdType="pubmed">29619403</ArticleId></ArticleIdList></Reference><Reference><Citation>Engen P.A., Zaferiou A., Rasmussen H., Naqib A., Green S.J., Fogg L.F., Forsyth C.B., Raeisi S., Hamaker B., Keshavarzian A. Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis. Front. Neurol. 2020;11:978. doi: 10.3389/fneur.2020.00978.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00978</ArticleId><ArticleId IdType="pmc">PMC7506051</ArticleId><ArticleId IdType="pubmed">33013647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward L., O&#x2019;Grady H., Wu K., Cannon K., Workentine M., Louie T. Open Forum Infectious Diseases. Oxford University Press; Oxford, UK: 2016. Combined oral fecal capsules plus fecal enema as treatment of late-onset autism spectrum disorder in children: Report of a small case series; p. 2219.</Citation></Reference><Reference><Citation>Qureshi F., Adams J., Hanagan K., Kang D.-W., Krajmalnik-Brown R., Hahn J. Multivariate Analysis of Fecal Metabolites from Children with Autism Spectrum Disorder and Gastrointestinal Symptoms before and after Microbiota Transfer Therapy. J. Pers. Med. 2020;10:152. doi: 10.3390/jpm10040152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10040152</ArticleId><ArticleId IdType="pmc">PMC7712156</ArticleId><ArticleId IdType="pubmed">33023268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D.-W., Adams J.B., Coleman D.M., Pollard E.L., Maldonado J., McDonough-Means S., Caporaso J.G., Krajmalnik-Brown R. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci. Rep. 2019;9:5821. doi: 10.1038/s41598-019-42183-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42183-0</ArticleId><ArticleId IdType="pmc">PMC6456593</ArticleId><ArticleId IdType="pubmed">30967657</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.Y., Seo G.S. Fecal Microbiota Transplantation: Is It Safe? Clin. Endosc. 2021;54:157&#x2013;160. doi: 10.5946/ce.2021.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.5946/ce.2021.072</ArticleId><ArticleId IdType="pmc">PMC8039753</ArticleId><ArticleId IdType="pubmed">33827154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Xu M., Wang W., Cao X., Piao M., Khan S., Yan F., Cao H., Wang B. Systematic review: Adverse events of fecal microbiota transplantation. PLoS ONE. 2016;11:e0161174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986962</ArticleId><ArticleId IdType="pubmed">27529553</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang R., Li L. Modulation of short-chain fatty acids as potential therapy method for type 2 diabetes mellitus. Can. J. Infect. Dis. Med. Microbiol. 2021;2021:6632266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801078</ArticleId><ArticleId IdType="pubmed">33488888</ArticleId></ArticleIdList></Reference><Reference><Citation>Breuer R., Soergel K., Lashner B., Christ M., Hanauer S., Vanagunas A., Harig J., Keshavarzian A., Robinson M., Sellin J. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: A randomised, placebo controlled trial. Gut. 1997;40:485&#x2013;491. doi: 10.1136/gut.40.4.485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.40.4.485</ArticleId><ArticleId IdType="pmc">PMC1027123</ArticleId><ArticleId IdType="pubmed">9176076</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P., Wang J., Hong F., Wang S., Jin X., Xue T., Jia L., Zhai Y. Melatonin prevents obesity through modulation of gut microbiota in mice. J. Pineal Res. 2017;62:e12399.</Citation><ArticleIdList><ArticleId IdType="pubmed">28199741</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.S., Kim S.H., Park J.W., Kho Y., Seok P.R., Shin J.H., Choi Y.J., Jun J.H., Jung H.C., Kim E.K. Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation. Intest. Res. 2020;18:325&#x2013;336. doi: 10.5217/ir.2019.00093.</Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2019.00093</ArticleId><ArticleId IdType="pmc">PMC7385569</ArticleId><ArticleId IdType="pubmed">32564539</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias A.M., Cordeiro G., Estevinho M.M., Veiga R., Figueira L., Reina-Couto M., Magro F., the Clinical Pharmacology Unit, S&#xe3;o Jo&#xe3;o Hospital University Centre Gut bacterial microbiome composition and statin intake&#x2014;A systematic review. Pharmacol. Res. Perspect. 2020;8:e00601. doi: 10.1002/prp2.601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.601</ArticleId><ArticleId IdType="pmc">PMC7261966</ArticleId><ArticleId IdType="pubmed">32476298</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira-Silva S., Falony G., Belda E., Nielsen T., Aron-Wisnewsky J., Chakaroun R., Forslund S.K., Assmann K., Valles-Colomer M., Nguyen T.T.D., et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature. 2020;581:310&#x2013;315. doi: 10.1038/s41586-020-2269-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2269-x</ArticleId><ArticleId IdType="pubmed">32433607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Li H., Zhao X., Zhou R., Liu H., Sun Y., Fan Y., Shi Y., Qiao S., Liu S., et al. Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome. Theranostics. 2021;11:5778&#x2013;5793. doi: 10.7150/thno.55946.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.55946</ArticleId><ArticleId IdType="pmc">PMC8058718</ArticleId><ArticleId IdType="pubmed">33897881</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D.Y., Li X.S., Chaikijurajai T., Li L., Wang Z., Hazen S.L., Tang W.H.W. Relation of Statin Use to Gut Microbial Trimethylamine N-Oxide and Cardiovascular Risk. Am. J. Cardiol. 2022;178:26&#x2013;34. doi: 10.1016/j.amjcard.2022.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2022.05.010</ArticleId><ArticleId IdType="pubmed">35787338</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xu J.-H., Yu T., Chen Q.-K. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. Biomed. Pharmacother. 2019;118:109131. doi: 10.1016/j.biopha.2019.109131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109131</ArticleId><ArticleId IdType="pubmed">31545226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Esteve E., Tremaroli V., Khan M.T., Caesar R., Manner&#xe5;s-Holm L., St&#xe5;hlman M., Olsson L.M., Serino M., Planas-F&#xe8;lix M. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 2017;23:850.</Citation><ArticleIdList><ArticleId IdType="pubmed">28530702</ArticleId></ArticleIdList></Reference><Reference><Citation>Whang A., Nagpal R., Yadav H. Bi-directional drug-microbiome interactions of anti-diabetics. EBioMedicine. 2019;39:591&#x2013;602. doi: 10.1016/j.ebiom.2018.11.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.046</ArticleId><ArticleId IdType="pmc">PMC6354569</ArticleId><ArticleId IdType="pubmed">30553752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Liu K., Yang H., Jin Z., Ding Q., Zhao L. Gut Microbiota: The Potential Key Target of TCM&#x2019;s Therapeutic Effect of Treating Different Diseases Using the Same Method&#x2014;UC and T2DM as Examples. Front. Cell. Infect. Microbiol. 2022;12:855075. doi: 10.3389/fcimb.2022.855075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.855075</ArticleId><ArticleId IdType="pmc">PMC9005880</ArticleId><ArticleId IdType="pubmed">35433500</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortea M., Albert-Bayo M., Abril-Gil M., Ganda Mall J.-P., Serra-Ruiz X., Henao-Paez A., Exp&#xf3;sito E., Gonz&#xe1;lez-Castro A.M., Guagnozzi D., Lobo B., et al. Present and Future Therapeutic Approaches to Barrier Dysfunction. Front. Nutr. 2021;8:718093. doi: 10.3389/fnut.2021.718093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.718093</ArticleId><ArticleId IdType="pmc">PMC8582318</ArticleId><ArticleId IdType="pubmed">34778332</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Bai B., Gao Z., Yang Y., Wu H., Wang X., Wang J., Li M., Tong X. Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome. Front. Cell. Infect. Microbiol. 2021;11:740236. doi: 10.3389/fcimb.2021.740236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.740236</ArticleId><ArticleId IdType="pmc">PMC8531589</ArticleId><ArticleId IdType="pubmed">34692563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Huang L., Zhou Z., Yin L., Tang J. Diallyl Disulfide (DADS) Ameliorates Intestinal Candida albicans Infection by Modulating the Gut microbiota and Metabolites and Providing Intestinal Protection in Mice. Front. Cell. Infect. Microbiol. 2022;11:742454. doi: 10.3389/fcimb.2021.743454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.743454</ArticleId><ArticleId IdType="pmc">PMC8777027</ArticleId><ArticleId IdType="pubmed">35071031</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Liao J., Ai Y., Gao J., Zhao J., Qu F., Xu C., Zhang Z., Wen W., Cui H., et al. Pi-Dan-Jian-Qing Decoction Ameliorates Type 2 Diabetes Mellitus Through Regulating the Gut Microbiota and Serum Metabolism. Front. Cell. Infect. Microbiol. 2021;11:748872. doi: 10.3389/fcimb.2021.748872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.748872</ArticleId><ArticleId IdType="pmc">PMC8685325</ArticleId><ArticleId IdType="pubmed">34938667</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin R., Liu S., Jiang X., Zhang X., Wei F., Hu J. The Qingchangligan Formula Alleviates Acute Liver Failure by Regulating Galactose Metabolism and Gut Microbiota. Front. Cell. Infect. Microbiol. 2022;11:771483. doi: 10.3389/fcimb.2021.771483.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.771483</ArticleId><ArticleId IdType="pmc">PMC8807683</ArticleId><ArticleId IdType="pubmed">35127552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang R., Yi J., Lu S., Chen B., Liu B. Therapeutic Effect of Buyang Huanwu Decoction on the Gut Microbiota and Hippocampal Metabolism in a Rat Model of Cerebral Ischemia. Front. Cell. Infect. Microbiol. 2022;12:734. doi: 10.3389/fcimb.2022.873096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.873096</ArticleId><ArticleId IdType="pmc">PMC9237419</ArticleId><ArticleId IdType="pubmed">35774407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Jiang J., Li Q., Liu X., Wang Z., Yang L., Ding L. Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function. Front. Cell. Infect. Microbiol. 2022;12:855008. doi: 10.3389/fcimb.2022.855008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.855008</ArticleId><ArticleId IdType="pmc">PMC9483129</ArticleId><ArticleId IdType="pubmed">36132991</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J.-Q., Wei S.-Y., Cheng N., Zhong Y.-B., Yu F.-H., Li M.-D., Liu D.-Y., Li S.-S., Zhao H.-M. Chimonanthus nitens Oliv. Leaf Granule Ameliorates DSS-Induced Acute Colitis Through Treg Cell Improvement, Oxidative Stress Reduction, and Gut Microflora Modulation. Front. Cell. Infect. Microbiol. 2022;12:907813. doi: 10.3389/fcimb.2022.907813.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.907813</ArticleId><ArticleId IdType="pmc">PMC9272890</ArticleId><ArticleId IdType="pubmed">35832382</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Zheng Y., Yang F., Feng Y., Xu K., Wu J., Qu S., Yu Z., Fan F., Huang L., et al. Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice. Front. Cell. Infect. Microbiol. 2022;12:921075. doi: 10.3389/fcimb.2022.921075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.921075</ArticleId><ArticleId IdType="pmc">PMC9395742</ArticleId><ArticleId IdType="pubmed">36017369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Chen R., Zheng D., Xiong F., Jia F., Liu J., Zhang L., Zhang N., Zhu S., Liu Y., et al. Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota. Front. Cell. Infect. Microbiol. 2022;12:854796. doi: 10.3389/fcimb.2022.854796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.854796</ArticleId><ArticleId IdType="pmc">PMC9127304</ArticleId><ArticleId IdType="pubmed">35619648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G., Zhang W., Zheng N., Zu X., Tian S., Zhong J., Zhang Y., Liao J., Sheng L., Ge G., et al. Integrated microbiome and metabolome analysis reveals the potential therapeutic mechanism of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia. Front. Cell. Infect. Microbiol. 2022;12:950983. doi: 10.3389/fcimb.2022.950983.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.950983</ArticleId><ArticleId IdType="pmc">PMC9461713</ArticleId><ArticleId IdType="pubmed">36093201</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Kang Y., Du Y., Chen M., Guo L., Huang X., Li T., Chen S., Yang F., Yu F., et al. Effects of Konjaku Flour on the Gut Microbiota of Obese Patients. Front. Cell. Infect. Microbiol. 2022;12:771748. doi: 10.3389/fcimb.2022.771748.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.771748</ArticleId><ArticleId IdType="pmc">PMC8921482</ArticleId><ArticleId IdType="pubmed">35300378</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Ni C., Li L., Li M., Jiang X., Gao L., Zhu H., Song J. Integrated Traditional Chinese Medicine Improves Functional Outcome in Acute Ischemic Stroke: From Clinic to Mechanism Exploration With Gut Microbiota. Front. Cell. Infect. Microbiol. 2022;12:827129. doi: 10.3389/fcimb.2022.827129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.827129</ArticleId><ArticleId IdType="pmc">PMC8877419</ArticleId><ArticleId IdType="pubmed">35223549</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabczyk M., Nowak J., Hudzik B., Zubelewicz-Szkodzi&#x144;ska B. Curcumin and Its Potential Impact on Microbiota. Nutrients. 2021;13:2004. doi: 10.3390/nu13062004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13062004</ArticleId><ArticleId IdType="pmc">PMC8230423</ArticleId><ArticleId IdType="pubmed">34200819</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C., Han Y., Li H., Yu H., Zhang B., Li G. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson&#x2019;s disease. Front. Cell. Infect. Microbiol. 2022;12:1086. doi: 10.3389/fcimb.2022.887407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.887407</ArticleId><ArticleId IdType="pmc">PMC9400544</ArticleId><ArticleId IdType="pubmed">36034698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Zhang Z., Liu J., Qi H., Li J., Chen J., Huang Q., Liu Q., Mi J., Li X. Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation. Front. Cell. Infect. Microbiol. 2022;12:456. doi: 10.3389/fcimb.2022.853981.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.853981</ArticleId><ArticleId IdType="pmc">PMC9084182</ArticleId><ArticleId IdType="pubmed">35548468</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon H., Kim H.-Y., Bae C.-H., Lee Y., Kim S. Korean Red ginseng regulates intestinal tight junction and inflammation in the colon of a Parkinson&#x2019;s disease mouse model. J. Med. Food. 2020;23:1231&#x2013;1237. doi: 10.1089/jmf.2019.4640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2019.4640</ArticleId><ArticleId IdType="pubmed">33121350</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong W., Zhao X., Xu Q., Wei G., Zhang L., Fan Y., Wen L., Liu Y., Zhang T., Zhang L. Qisheng Wan formula ameliorates cognitive impairment of Alzheimer&#x2019;s disease rat via inflammation inhibition and intestinal microbiota regulation. J. Ethnopharmacol. 2022;282:114598.</Citation><ArticleIdList><ArticleId IdType="pubmed">34492320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Lu J., Zeng Y., Guo Y., Wu C., Zhao H., Zheng H., Jiao J. Improving Alzheimer&#x2019;s disease by altering gut microbiota in tree shrews with ginsenoside Rg1. FEMS Microbiol. Lett. 2020;367:fnaa011. doi: 10.1093/femsle/fnaa011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsle/fnaa011</ArticleId><ArticleId IdType="pubmed">31950993</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C., Yu J., Yang Y., Zhang F., Su W., Fan Q., Wu C., Wu S. Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomed. Pharmacother. 2021;139:111595. doi: 10.1016/j.biopha.2021.111595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111595</ArticleId><ArticleId IdType="pubmed">33862492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Zhang H., Gao Z., Zhang Q., Gu C. The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Front. Cell. Infect. Microbiol. 2022;12:854885. doi: 10.3389/fcimb.2022.854885.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.854885</ArticleId><ArticleId IdType="pmc">PMC9452888</ArticleId><ArticleId IdType="pubmed">36093200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao C., Wu L., Wang D., Chen L., Jin X., Shi Y., Li G., Zhang J., Zeng X., Chen J., et al. Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn&#x2019;s disease: A randomized controlled trial. eClinicalMedicine. 2022;45:101300. doi: 10.1016/j.eclinm.2022.101300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101300</ArticleId><ArticleId IdType="pmc">PMC8850329</ArticleId><ArticleId IdType="pubmed">35198926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao C., Wu L., Shi Y., Wu H., Liu H., Zhang R., Yu L., Wang J. Moxibustion down-regulates colonic epithelial cell apoptosis and repairs tight junctions in rats with Crohn&#x2019;s disease. World J. Gastroenterol. 2011;17:4960&#x2013;4970. doi: 10.3748/wjg.v17.i45.4960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i45.4960</ArticleId><ArticleId IdType="pmc">PMC3236582</ArticleId><ArticleId IdType="pubmed">22174545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei D., Xie L., Zhuang Z., Zhao N., Huang B., Tang Y., Yu S., Zhou Q., Wu Q. Gut microbiota: A new strategy to study the mechanism of electroacupuncture and moxibustion in treating ulcerative colitis. Evid.-Based Complement. Altern. Med. 2019;2019:9730176. doi: 10.1155/2019/9730176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9730176</ArticleId><ArticleId IdType="pmc">PMC6632505</ArticleId><ArticleId IdType="pubmed">31354859</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Q., Liu Y.-N., Jin X.-M., Zhang L.-S., Wang C., Bao C.-H., Liu H.-R., Wu H.-G., Wang X.-M. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model. World J. Gastroenterol. 2018;24:3130. doi: 10.3748/wjg.v24.i28.3130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v24.i28.3130</ArticleId><ArticleId IdType="pmc">PMC6064969</ArticleId><ArticleId IdType="pubmed">30065559</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Q., Liu Y.-N., Lv S.-Y., Wu H.-G., Zhang L.-S., Cao Z., Liu H.-R., Wang X.-M., Wu L.-Y. Gut microbiome alterations in colitis rats after moxibustion at bilateral Tianshu acupoints. BMC Gastroenterol. 2022;22:62. doi: 10.1186/s12876-022-02115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-022-02115-1</ArticleId><ArticleId IdType="pmc">PMC8840236</ArticleId><ArticleId IdType="pubmed">35151255</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Qi Q., Wang Y., Wu H., Jin X., Yao H., Jin D., Liu Y., Wang C. Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome. Chin. Med. 2018;13:63. doi: 10.1186/s13020-018-0220-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-018-0220-y</ArticleId><ArticleId IdType="pmc">PMC6299671</ArticleId><ArticleId IdType="pubmed">30574173</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao C.H., Wang C.Y., Li G.N., Yan Y.L., Wang D., Jin X.M., Wu L.Y., Liu H.R., Wang X.M., Shi Z., et al. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome. World J. Gastroenterol. 2019;25:4696&#x2013;4714. doi: 10.3748/wjg.v25.i32.4696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v25.i32.4696</ArticleId><ArticleId IdType="pmc">PMC6718040</ArticleId><ArticleId IdType="pubmed">31528095</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang J.-H., Yeom M.-J., Ahn S., Oh J.-Y., Ji S., Kim T.-H., Park H.-J. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson&#x2019;s disease. Brain Behav. Immun. 2020;89:641&#x2013;655. doi: 10.1016/j.bbi.2020.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.08.015</ArticleId><ArticleId IdType="pubmed">32827699</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Wang Y., Liu Z., Guo J., Li J., Zhao Y. Improvement effect of acupuncture on locomotor function in Parkinson disease via regulating gut microbiota and inhibiting inflammatory factor release. J. Acupunct. Tuina Sci. 2022;20:339&#x2013;353. doi: 10.1007/s11726-022-1297-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11726-022-1297-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazarova L., Liu H., Xie H., Wang L., Ding H., An H., Huang D. Targeting gut-brain axis through scalp-abdominal electroacupuncture in Parkinson&#x2019;s disease. Brain Res. 2022;1790:147956. doi: 10.1016/j.brainres.2022.147956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2022.147956</ArticleId><ArticleId IdType="pubmed">35660372</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., He M., Chen X., Sun M., Pan T., Xu X., Zhang X., Gong Q., Zhao Y., Jin Z. Acupuncture effect assessment in APP/PS1 transgenic mice: On regulating learning-memory abilities, gut microbiota, and microbial metabolites. Comput. Math. Methods Med. 2022;2022:1527159. doi: 10.1155/2022/1527159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1527159</ArticleId><ArticleId IdType="pmc">PMC9012623</ArticleId><ArticleId IdType="pubmed">35432583</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham V.T., Dold S., Rehman A., Bird J.K., Steinert R.E. Vitamins, the gut microbiome and gastrointestinal health in humans. Nutr. Res. 2021;95:35&#x2013;53. doi: 10.1016/j.nutres.2021.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2021.09.001</ArticleId><ArticleId IdType="pubmed">34798467</ArticleId></ArticleIdList></Reference><Reference><Citation>Francino M. Antibiotics and the human gut microbiome: Dysbioses and accumulation of resistances. Front. Microbiol. 2016;6:1543. doi: 10.3389/fmicb.2015.01543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2015.01543</ArticleId><ArticleId IdType="pmc">PMC4709861</ArticleId><ArticleId IdType="pubmed">26793178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156:3216&#x2013;3223. doi: 10.1099/mic.0.040618-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/mic.0.040618-0</ArticleId><ArticleId IdType="pubmed">20705661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianiro G., Tilg H., Gasbarrini A. Antibiotics as deep modulators of gut microbiota: Between good and evil. Gut. 2016;65:1906&#x2013;1915. doi: 10.1136/gutjnl-2016-312297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-312297</ArticleId><ArticleId IdType="pubmed">27531828</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewardson A.J., Ga&#xef;a N., Francois P., Malhotra-Kumar S., Delemont C., de Tejada B.M., Schrenzel J., Harbarth S., Lazarevic V., WP S. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: A culture-free analysis of gut microbiota. Clin. Microbiol. Infect. 2015;21:344.e1&#x2013;344.e11. doi: 10.1016/j.cmi.2014.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2014.11.016</ArticleId><ArticleId IdType="pubmed">25658522</ArticleId></ArticleIdList></Reference><Reference><Citation>Vervoort J., Xavier B.B., Stewardson A., Coenen S., Godycki-Cwirko M., Adriaenssens N., Kowalczyk A., Lammens C., Harbarth S., Goossens H., et al. Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota. J. Antimicrob. Chemother. 2015;70:1989&#x2013;1992. doi: 10.1093/jac/dkv062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkv062</ArticleId><ArticleId IdType="pubmed">25766736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponziani F.R., Zocco M.A., D&#x2019;Aversa F., Pompili M., Gasbarrini A. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J. Gastroenterol. 2017;23:4491&#x2013;4499. doi: 10.3748/wjg.v23.i25.4491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v23.i25.4491</ArticleId><ArticleId IdType="pmc">PMC5504364</ArticleId><ArticleId IdType="pubmed">28740337</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Xiang Y., Zhu Z., Wang W., Jiang Z., Zhao M., Cheng S., Pan F., Liu D., Ho R.C.M., et al. Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat. J. Neuroinflamm. 2021;18:254. doi: 10.1186/s12974-021-02303-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02303-y</ArticleId><ArticleId IdType="pmc">PMC8567657</ArticleId><ArticleId IdType="pubmed">34736493</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.S.C., Bhagatwala J. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management. Clin. Transl. Gastroenterol. 2019;10:e00078. doi: 10.14309/ctg.0000000000000078.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000078</ArticleId><ArticleId IdType="pmc">PMC6884350</ArticleId><ArticleId IdType="pubmed">31584459</ArticleId></ArticleIdList></Reference><Reference><Citation>Sroka N., Rydzewska-Roso&#x142;owska A., Kakareko K., Roso&#x142;owski M., G&#x142;owi&#x144;ska I., Hryszko T. Show Me What You Have Inside&#x2014;The Complex Interplay between SIBO and Multiple Medical Conditions&#x2014;A Systematic Review. Nutrients. 2023;15:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9824151</ArticleId><ArticleId IdType="pubmed">36615748</ArticleId></ArticleIdList></Reference><Reference><Citation>Prantera C., Lochs H., Grimaldi M., Danese S., Scribano M.L., Gionchetti P. Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn&#x2019;s Disease. Gastroenterology. 2012;142:473&#x2013;481.e4. doi: 10.1053/j.gastro.2011.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2011.11.032</ArticleId><ArticleId IdType="pubmed">22155172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong C.-T., Chan L., Chen K.-Y., Lee H.-H., Huang L.-K., Yang Y.-C.S., Liu Y.-R., Hu C.-J. Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson&#x2019;s Disease: Preclinical and Clinical Studies. Cells. 2022;11:3468. doi: 10.3390/cells11213468.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11213468</ArticleId><ArticleId IdType="pmc">PMC9656351</ArticleId><ArticleId IdType="pubmed">36359864</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhocki P.V., Ronald J.S., Diehl A.M.E., Murdoch D.M., Doraiswamy P.M. Probing gut-brain links in Alzheimer&#x2019;s disease with rifaximin. Alzheimers Dement. 2022;8:e12225. doi: 10.1002/trc2.12225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12225</ArticleId><ArticleId IdType="pmc">PMC8804600</ArticleId><ArticleId IdType="pubmed">35128026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., V&#xe4;is&#xe4;nen M.-L., Nelson M.N., Wexler H.M. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 2000;15:429&#x2013;435. doi: 10.1177/088307380001500701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/088307380001500701</ArticleId><ArticleId IdType="pubmed">10921511</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrenovich M., Jaworski H., Tadimalla T., Mistry A., Sykes L., Perry G., Bonomo R.A. The role of the microbiota&#x2013;gut&#x2013;brain axis and antibiotics in ALS and neurodegenerative diseases. Microorganisms. 2020;8:784. doi: 10.3390/microorganisms8050784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8050784</ArticleId><ArticleId IdType="pmc">PMC7285349</ArticleId><ArticleId IdType="pubmed">32456229</ArticleId></ArticleIdList></Reference><Reference><Citation>Melzer N., Meuth S.G., Torres-Salazar D., Bittner S., Zozulya A.L., Weidenfeller C., Kotsiari A., Stangel M., Fahlke C., Wiendl H. A &#x3b2;-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis. PLoS ONE. 2008;3:e3149. doi: 10.1371/annotation/b898d6ee-801a-474e-9776-72e4da664b89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/b898d6ee-801a-474e-9776-72e4da664b89</ArticleId><ArticleId IdType="pmc">PMC2522272</ArticleId><ArticleId IdType="pubmed">18773080</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J.-C., Tikhonova M.A., Chen J.-H., Shen M.-S., Meng W.-Y., Chang Y.-T., Chen K.-H., Liang K.-C., Hung C.-S., Amstislavskaya T.G., et al. Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson&#x2019;s disease rat model: An immunohistochemical and MRI study. Behav. Brain Res. 2016;305:126&#x2013;139. doi: 10.1016/j.bbr.2016.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2016.02.034</ArticleId><ArticleId IdType="pubmed">26940602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari S., Deshmukh R. &#x3b2;-lactam antibiotics to tame down molecular pathways of Alzheimer&#x2019;s disease. Eur. J. Pharmacol. 2021;895:173877. doi: 10.1016/j.ejphar.2021.173877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.173877</ArticleId><ArticleId IdType="pubmed">33453224</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai C.-H., Bellesi M., Chen A.-C., Lin C.-L., Li H.-H., Lin P.-J., Liao W.-C., Hung C.-S., Schwarting R.K., Ho Y.-J. A new avenue for treating neuronal diseases: Ceftriaxone, an old antibiotic demonstrating behavioral neuronal effects. Behav. Brain Res. 2019;364:149&#x2013;156. doi: 10.1016/j.bbr.2019.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2019.02.020</ArticleId><ArticleId IdType="pubmed">30768995</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikhonova M.A., Ho S.-C., Akopyan A.A., Kolosova N.G., Weng J.-C., Meng W.-Y., Lin C.-L., Amstislavskaya T.G., Ho Y.-J. Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence. Behav. Brain Res. 2017;330:8&#x2013;16. doi: 10.1016/j.bbr.2017.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2017.05.002</ArticleId><ArticleId IdType="pubmed">28487222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamblin M.R. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem. Photobiol. 2018;94:199&#x2013;212. doi: 10.1111/php.12864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/php.12864</ArticleId><ArticleId IdType="pmc">PMC5844808</ArticleId><ArticleId IdType="pubmed">29164625</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson P., Kim J.Y., Riveros C., Camp A., Johnstone D.M. Elucidating the time course of the transcriptomic response to photobiomodulation through gene co-expression analysis. J. Photochem. Photobiol. B Biol. 2020;208:111916. doi: 10.1016/j.jphotobiol.2020.111916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2020.111916</ArticleId><ArticleId IdType="pubmed">32480201</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow R.T., Johnson M.I., Lopes-Martins R.A., Bjordal J.M. Efficacy of low-level laser therapy in the management of neck pain: A systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet. 2009;374:1897&#x2013;1908. doi: 10.1016/S0140-6736(09)61522-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61522-1</ArticleId><ArticleId IdType="pubmed">19913903</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow R.T., David M.A., Armati P.J. 830 nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root ganglion neurons: Implications for the analgesic effects of 830 nm laser. J. Peripher. Nerv. Syst. 2007;12:28&#x2013;39. doi: 10.1111/j.1529-8027.2007.00114.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1529-8027.2007.00114.x</ArticleId><ArticleId IdType="pubmed">17374099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamblin M.R. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4:337&#x2013;361. doi: 10.3934/biophy.2017.3.337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/biophy.2017.3.337</ArticleId><ArticleId IdType="pmc">PMC5523874</ArticleId><ArticleId IdType="pubmed">28748217</ArticleId></ArticleIdList></Reference><Reference><Citation>El Massri N., Johnstone D.M., Peoples C.L., Moro C., Reinhart F., Torres N., Stone J., Benabid A.-L., Mitrofanis J. The effect of different doses of near infrared light on dopaminergic cell survival and gliosis in MPTP-treated mice. Int. J. Neurosci. 2016;126:76&#x2013;87. doi: 10.3109/00207454.2014.994063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2014.994063</ArticleId><ArticleId IdType="pubmed">25469453</ArticleId></ArticleIdList></Reference><Reference><Citation>El Massri N., Mitrofanis J. The experimental evidence for photobiomodulation-induced cellular and behavioral changes in animal models of Parkinson&#x2019;s disease: A template for translation to patients. In: Hamblin M.R., Huang Y.-Y., editors. Photobiomodulation in the Brain. Elsevier; London, UK: 2019. pp. 219&#x2013;231.</Citation></Reference><Reference><Citation>El Massri N., Moro C., Torres N., Darlot F., Agay D., Chabrol C., Johnstone D.M., Stone J., Benabid A.-L., Mitrofanis J. Near-infrared light treatment reduces astrogliosis in MPTP-treated monkeys. Exp. Brain Res. 2016;234:3225&#x2013;3232. doi: 10.1007/s00221-016-4720-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-016-4720-7</ArticleId><ArticleId IdType="pubmed">27377070</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganeshan V., Skladnev N.V., Kim J.Y., Mitrofanis J., Stone J., Johnstone D.M. Pre-conditioning with remote photobiomodulation modulates the brain transcriptome and protects against MPTP insult in mice. Neuroscience. 2019;400:85&#x2013;97. doi: 10.1016/j.neuroscience.2018.12.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.12.050</ArticleId><ArticleId IdType="pubmed">30625333</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone D.M., el Massri N., Moro C., Spana S., Wang X.S., Torres N., Chabrol C., De Jaeger X., Reinhart F., Purushothuman S., et al. Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism&#x2014;An abscopal neuroprotective effect. Neuroscience. 2014;274:93&#x2013;101. doi: 10.1016/j.neuroscience.2014.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.05.023</ArticleId><ArticleId IdType="pubmed">24857852</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone D.M., Mitrofanis J., Stone J. Targeting the body to protect the brain: Inducing neuroprotection with remotely-applied near infrared light. Neural Regen. Res. 2015;10:349&#x2013;351. doi: 10.4103/1673-5374.153673.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.153673</ArticleId><ArticleId IdType="pmc">PMC4396086</ArticleId><ArticleId IdType="pubmed">25878572</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J., Johnstone D., Mitrofanis J. The helmet experiment in Parkinson&#x2019;s disease: An observation of the mechanism of neuroprotection by near infra-red light; Proceedings of the 9th WALT Congress; Gold Coast, QLD, Australia. 28&#x2013;30 September 2012.</Citation></Reference><Reference><Citation>Wang M., Cao J., Amakye W.K., Gong C., Li Q., Ren J. Mid infrared light treatment attenuates cognitive decline and alters the gut microbiota community in APP/PS1 mouse model. Biochem. Biophys. Res. Commun. 2020;523:60&#x2013;65. doi: 10.1016/j.bbrc.2019.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.12.015</ArticleId><ArticleId IdType="pubmed">31831179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Jinpeng W.U., Dong X., Yin H., Shi X., Siying S.U., Che B., Yingxin L.I., Yang J. Gut flora-targeted photobiomodulation therapy improves senile dementia in an A&#xdf;-induced Alzheimer&#x2019;s disease animal model. J. Photochem. Photobiol. B Biol. 2021;216:112152. doi: 10.1016/j.jphotobiol.2021.112152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2021.112152</ArticleId><ArticleId IdType="pubmed">33610085</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubaud Baudron C., Letenneur L., Langlais A., Buissonni&#xe8;re A., M&#xe9;graud F., Dartigues J.-F., Salles N., Personnes Ag&#xe9;es QUID Study Does Helicobacter pylori Infection Increase Incidence of Dementia? The Personnes Ag&#xe9;es QUID Study. J. Am. Geriatr. Soc. 2013;61:74&#x2013;78. doi: 10.1111/jgs.12065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12065</ArticleId><ArticleId IdType="pubmed">23252507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Yang J., Dong C., Fu Y., Liu H. Gut microbiome-mediated changes in bone metabolism upon infrared light exposure in rats. J. Photochem. Photobiol. B Biol. 2021;217:112156. doi: 10.1016/j.jphotobiol.2021.112156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2021.112156</ArticleId><ArticleId IdType="pubmed">33647735</ArticleId></ArticleIdList></Reference><Reference><Citation>Min S.H., Kwon J., Do E.-J., Kim S.H., Kim E.S., Jeong J.-Y., Bae S.M., Kim S.-Y., Park D.H. Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model. Cells. 2022;11:3490. doi: 10.3390/cells11213490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11213490</ArticleId><ArticleId IdType="pmc">PMC9654760</ArticleId><ArticleId IdType="pubmed">36359885</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicknell B., Liebert A., McLachlan C.S., Kiat H. Microbiome Changes in Humans with Parkinson&#x2019;s Disease after Photobiomodulation Therapy: A Retrospective Study. J. Pers. Med. 2022;12:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778696</ArticleId><ArticleId IdType="pubmed">35055364</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebert A., Bicknell B., Laakso E.L., Heller G., Jalilitabaei P., Tilley S., Mitrofanis J., Kiat H. Improvements in clinical signs of Parkinson&#x2019;s disease using photobiomodulation: A prospective proof-of-concept study. BMC Neurol. 2021;21:256. doi: 10.1186/s12883-021-02248-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02248-y</ArticleId><ArticleId IdType="pmc">PMC8249215</ArticleId><ArticleId IdType="pubmed">34215216</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebert A., Bicknell B., Laakso E.-L., Jalilitabaei P., Tilley S., Kiat H., Mitrofanis J. Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson&#x2019;s Disease: A Case Series Conducted During COVID-19. Photobiomodul. Photomed. Laser Surg. 2022;40:112&#x2013;122. doi: 10.1089/photob.2021.0056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/photob.2021.0056</ArticleId><ArticleId IdType="pubmed">34919459</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso F.D.S., Gonzalez-Lima F., Coimbra N.C. Mitochondrial Photobiomodulation as a Neurotherapeutic Strategy for Epilepsy. Front. Neurol. 2022;13:873496. doi: 10.3389/fneur.2022.873496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.873496</ArticleId><ArticleId IdType="pmc">PMC9243228</ArticleId><ArticleId IdType="pubmed">35785362</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebert A.D., Bicknell B. Mechanisms of Photobiomodulation Therapy XII. SPIE; San Francisco, CA, USA: 2017. Clinical trial involving sufferers and non-sufferers of cervicogenic headache (CGH): Potential mechanisms of action of photobiomodulation; p. 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/12.2251773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian J., Liebert A., Bicknell B., Chen X.-M., Huang C., Pollock C.A. Therapeutic potential of photobiomodulation for chronic kidney disease. Int. J. Mol. Sci. 2022;23:8043. doi: 10.3390/ijms23148043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23148043</ArticleId><ArticleId IdType="pmc">PMC9320354</ArticleId><ArticleId IdType="pubmed">35887386</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldieraro M.A., Cassano P. Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms. J. Affect. Disord. 2019;243:262&#x2013;273. doi: 10.1016/j.jad.2018.09.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2018.09.048</ArticleId><ArticleId IdType="pubmed">30248638</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolentino M., Cho C.C., Lyons J.-A. Photobiomodulation therapy (PBMT) regulates the production of IL-10 and IFN-&#x194; by peripheral blood mononuclear cells (PBMC) and CD4+ T cells isolated from subjects with Multiple Sclerosis (MS) J. Immunol. 2019;202:193.16. doi: 10.4049/jimmunol.202.Supp.193.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.202.Supp.193.16</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceranoglu T.A., Cassano P., Hoskova B., Green A., Dallenbach N., DiSalvo M., Biederman J., Joshi G. Transcranial photobiomodulation in adults with high-functioning autism spectrum disorder: Positive findings from a proof-of-concept study. Photobiomodul. Photomed. Laser Surg. 2022;40:4&#x2013;12. doi: 10.1089/photob.2020.4986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/photob.2020.4986</ArticleId><ArticleId IdType="pubmed">34941429</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen R., Arany P.R. Use of either Transcranial or Whole-Body Photobiomodulation Treatments improves COVID-19 Brain Fog. J. Biophotonics. 2023:e202200391. doi: 10.1002/jbio.202200391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.202200391</ArticleId><ArticleId IdType="pubmed">37018063</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeser M.A., Ho M.D., Martin P.I., Hamblin M.R., Koo B.-B. Increased functional connectivity within intrinsic neural networks in chronic stroke following treatment with red/near-infrared transcranial photobiomodulation: Case series with improved naming in aphasia. Photobiomodul. Photomed. Laser Surg. 2020;38:115&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">31621498</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehpour F., Khademi M., Hamblin M.R. Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies. J. Alzheimer&#x2019;s Dis. 2021;83:1431&#x2013;1452. doi: 10.3233/JAD-210029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210029</ArticleId><ArticleId IdType="pubmed">33935090</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehpour F., Gholipour-Khalili S., Farajdokht F., Kamari F., Walski T., Hamblin M.R., DiDuro J.O., Cassano P. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: A narrative review. Rev. Neurosci. 2020;31:269&#x2013;286. doi: 10.1515/revneuro-2019-0063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2019-0063</ArticleId><ArticleId IdType="pmc">PMC7138738</ArticleId><ArticleId IdType="pubmed">31812948</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens A.R., Hadis M., Milward M., Ahmed Z., Belli A., Palin W., Davies D.J. Photobiomodulation in acute traumatic brain injury: A systematic review and meta-analysis. J. Neurotrauma. 2023;40:210&#x2013;227. doi: 10.1089/neu.2022.0140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2022.0140</ArticleId><ArticleId IdType="pubmed">35698294</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>